Submitted URL: https://u27622772.ct.sendgrid.net/ls/click?upn=mLRiRs4fGxEXMjgAuR5aaTG-2Fv2eHhn-2Bq6YGnhsdclwDS-2FcPOMoNjvjwrFJh-2BwwLHc7iVTGL-2BK...
Effective URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yie...
Submission: On September 21 via api from US — Scanned from DE

Summary

This website contacted 43 IPs in 5 countries across 35 domains to perform 135 HTTP transactions. The main IP is 76.76.21.123, located in United States and belongs to AMAZON-02, US. The main domain is www.cancernetwork.com. The Cisco Umbrella rank of the primary domain is 639931.
TLS certificate: Issued by R3 on July 28th 2022. Valid for: 3 months.
This is the only time www.cancernetwork.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 1 167.89.115.121 11377 (SENDGRID)
8 23.36.162.19 20940 (AKAMAI-ASN1)
1 2606:4700::68... 13335 (CLOUDFLAR...)
2 2a00:1450:400... 15169 (GOOGLE)
5 104.75.88.126 16625 (AKAMAI-AS)
4 2a00:1450:400... 15169 (GOOGLE)
8 2a00:1450:400... 15169 (GOOGLE)
4 2a00:1450:400... 15169 (GOOGLE)
1 2a02:26f0:11a... 20940 (AKAMAI-ASN1)
5 2a00:1450:400... 15169 (GOOGLE)
1 23.35.237.151 16625 (AKAMAI-AS)
33 76.76.21.123 16509 (AMAZON-02)
2 2a00:1450:400... 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
1 2001:4860:480... 15169 (GOOGLE)
3 3 2620:1ec:21::14 8068 (MICROSOFT...)
1 13.107.42.14 8068 (MICROSOFT...)
1 2001:4860:480... 15169 (GOOGLE)
1 2600:9000:223... 16509 (AMAZON-02)
1 35.244.182.184 15169 (GOOGLE)
5 2606:4700::68... 13335 (CLOUDFLAR...)
3 2a00:1450:400... 15169 (GOOGLE)
1 52.216.80.240 16509 (AMAZON-02)
3 35.190.70.79 15169 (GOOGLE)
5 18.66.115.169 16509 (AMAZON-02)
1 18.66.97.37 16509 (AMAZON-02)
1 151.101.129.131 54113 (FASTLY)
2 2606:4700::68... 13335 (CLOUDFLAR...)
2 2a03:2880:f01... 32934 (FACEBOOK)
1 5 2600:9000:225... 16509 (AMAZON-02)
1 20.40.202.0 8075 (MICROSOFT...)
3 4 34.102.246.198 396982 (GOOGLE-CL...)
4 5 185.89.210.141 29990 (ASN-APPNEX)
2 15.197.193.217 16509 (AMAZON-02)
3 2a00:1450:400... 15169 (GOOGLE)
1 52.222.236.122 16509 (AMAZON-02)
1 108.138.17.27 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
1 18.66.147.113 16509 (AMAZON-02)
2 52.213.31.46 16509 (AMAZON-02)
2 2a03:2880:f11... 32934 (FACEBOOK)
1 63.33.188.239 16509 (AMAZON-02)
2 52.25.176.52 16509 (AMAZON-02)
2 54.220.167.71 16509 (AMAZON-02)
135 43
Apex Domain
Subdomains
Transfer
33 cancernetwork.com
www.cancernetwork.com — Cisco Umbrella Rank: 639931
640 KB
9 doubleclick.net
stats.g.doubleclick.net — Cisco Umbrella Rank: 79
securepubads.g.doubleclick.net — Cisco Umbrella Rank: 180
googleads.g.doubleclick.net — Cisco Umbrella Rank: 41
160 KB
9 google-analytics.com
www.google-analytics.com — Cisco Umbrella Rank: 27
region1.google-analytics.com — Cisco Umbrella Rank: 2989
64 KB
8 caboodleai.net
ins1.caboodleai.net
499 KB
6 adroll.com
s.adroll.com — Cisco Umbrella Rank: 2439
d.adroll.com — Cisco Umbrella Rank: 1453
79 KB
5 adnxs.com
secure.adnxs.com — Cisco Umbrella Rank: 432
4 KB
5 segment.com
cdn.segment.com — Cisco Umbrella Rank: 1475
37 KB
5 lightboxcdn.com
www.lightboxcdn.com — Cisco Umbrella Rank: 6595
148 KB
4 lhmos.com
trc.lhmos.com — Cisco Umbrella Rank: 12387
2 KB
4 doubleverify.com
pub.doubleverify.com — Cisco Umbrella Rank: 5890
vtrk.doubleverify.com — Cisco Umbrella Rank: 1474
19 KB
4 linkedin.com
px.ads.linkedin.com — Cisco Umbrella Rank: 394
www.linkedin.com — Cisco Umbrella Rank: 623
px4.ads.linkedin.com — Cisco Umbrella Rank: 6198
4 KB
4 gstatic.com
fonts.gstatic.com
91 KB
4 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 62
275 KB
4 addthis.com
s7.addthis.com — Cisco Umbrella Rank: 1571
m.addthis.com — Cisco Umbrella Rank: 1521
217 KB
3 hotjar.com
static.hotjar.com — Cisco Umbrella Rank: 591
script.hotjar.com — Cisco Umbrella Rank: 779
vars.hotjar.com — Cisco Umbrella Rank: 852
68 KB
3 sanity.io
cdn.sanity.io — Cisco Umbrella Rank: 17132
14 KB
3 googlesyndication.com
pagead2.googlesyndication.com — Cisco Umbrella Rank: 105
236 KB
3 google.de
www.google.de — Cisco Umbrella Rank: 6352
671 B
3 google.com
www.google.com — Cisco Umbrella Rank: 2
region1.analytics.google.com — Cisco Umbrella Rank: 5636
913 B
2 vercel-insights.com
vitals.vercel-insights.com — Cisco Umbrella Rank: 11914
267 B
2 segment.io
api.segment.io — Cisco Umbrella Rank: 1011
355 B
2 facebook.com
www.facebook.com — Cisco Umbrella Rank: 113
427 B
2 adsrvr.org
match.adsrvr.org — Cisco Umbrella Rank: 342
529 B
2 facebook.net
connect.facebook.net — Cisco Umbrella Rank: 152
111 KB
2 ubembed.com
a5122525b8ca47d59e1e515e20e1c65a.js.ubembed.com
assets.ubembed.com — Cisco Umbrella Rank: 9660
48 KB
2 googleapis.com
fonts.googleapis.com — Cisco Umbrella Rank: 40
2 KB
1 azurewebsites.net
lightboxapi.azurewebsites.net — Cisco Umbrella Rank: 7505
798 B
1 amazonaws.com
mjh-web.s3.amazonaws.com — Cisco Umbrella Rank: 228589
19 KB
1 lassomarketing.io
res.lassomarketing.io — Cisco Umbrella Rank: 48161
2 KB
1 osano.com
cmp.osano.com — Cisco Umbrella Rank: 6731
53 KB
1 addthisedge.com
v1.addthisedge.com — Cisco Umbrella Rank: 1765
804 B
1 moatads.com
z.moatads.com — Cisco Umbrella Rank: 403
1 KB
1 licdn.com
snap.licdn.com — Cisco Umbrella Rank: 769
3 KB
1 bootstrapcdn.com
maxcdn.bootstrapcdn.com — Cisco Umbrella Rank: 691
5 KB
1 sendgrid.net
u27622772.ct.sendgrid.net
292 B
135 35
Domain Requested by
33 www.cancernetwork.com ins1.caboodleai.net
www.cancernetwork.com
8 www.google-analytics.com ins1.caboodleai.net
www.google-analytics.com
www.googletagmanager.com
www.cancernetwork.com
8 ins1.caboodleai.net ins1.caboodleai.net
5 secure.adnxs.com 4 redirects www.cancernetwork.com
5 s.adroll.com 1 redirects ins1.caboodleai.net
www.cancernetwork.com
s.adroll.com
5 cdn.segment.com www.cancernetwork.com
cdn.segment.com
5 www.lightboxcdn.com www.cancernetwork.com
www.lightboxcdn.com
5 stats.g.doubleclick.net www.google-analytics.com
www.googletagmanager.com
4 trc.lhmos.com 3 redirects www.cancernetwork.com
4 fonts.gstatic.com fonts.googleapis.com
4 www.googletagmanager.com ins1.caboodleai.net
www.googletagmanager.com
www.cancernetwork.com
3 securepubads.g.doubleclick.net www.cancernetwork.com
securepubads.g.doubleclick.net
3 cdn.sanity.io www.cancernetwork.com
3 pagead2.googlesyndication.com www.cancernetwork.com
pagead2.googlesyndication.com
3 www.google.de www.cancernetwork.com
3 s7.addthis.com ins1.caboodleai.net
s7.addthis.com
2 vitals.vercel-insights.com www.cancernetwork.com
2 api.segment.io cdn.segment.com
2 www.facebook.com www.cancernetwork.com
2 vtrk.doubleverify.com pub.doubleverify.com
2 match.adsrvr.org www.cancernetwork.com
2 connect.facebook.net ins1.caboodleai.net
connect.facebook.net
2 pub.doubleverify.com www.googletagmanager.com
pub.doubleverify.com
2 px.ads.linkedin.com 2 redirects
2 www.google.com www.cancernetwork.com
2 fonts.googleapis.com ins1.caboodleai.net
www.cancernetwork.com
1 d.adroll.com s.adroll.com
1 vars.hotjar.com static.hotjar.com
1 googleads.g.doubleclick.net pagead2.googlesyndication.com
1 assets.ubembed.com a5122525b8ca47d59e1e515e20e1c65a.js.ubembed.com
1 script.hotjar.com static.hotjar.com
1 lightboxapi.azurewebsites.net www.lightboxcdn.com
1 a5122525b8ca47d59e1e515e20e1c65a.js.ubembed.com www.googletagmanager.com
1 static.hotjar.com www.googletagmanager.com
1 mjh-web.s3.amazonaws.com www.cancernetwork.com
1 res.lassomarketing.io www.cancernetwork.com
1 cmp.osano.com www.cancernetwork.com
1 region1.google-analytics.com www.googletagmanager.com
1 px4.ads.linkedin.com
1 www.linkedin.com 1 redirects
1 region1.analytics.google.com www.googletagmanager.com
1 m.addthis.com s7.addthis.com
1 v1.addthisedge.com s7.addthis.com
1 z.moatads.com s7.addthis.com
1 snap.licdn.com www.googletagmanager.com
1 maxcdn.bootstrapcdn.com ins1.caboodleai.net
1 u27622772.ct.sendgrid.net 1 redirects
135 47
Subject Issuer Validity Valid
*.caboodleai.net
DigiCert TLS RSA SHA256 2020 CA1
2022-06-06 -
2023-06-08
a year crt.sh
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2022-01-29 -
2023-01-29
a year crt.sh
upload.video.google.com
GTS CA 1C3
2022-08-29 -
2022-11-21
3 months crt.sh
odc-addthis-prod-01.oracle.com
DigiCert SHA2 Secure Server CA
2022-02-27 -
2023-02-28
a year crt.sh
*.google-analytics.com
GTS CA 1C3
2022-09-05 -
2022-11-28
3 months crt.sh
*.gstatic.com
GTS CA 1C3
2022-08-29 -
2022-11-21
3 months crt.sh
snap.licdn.com
DigiCert SHA2 Secure Server CA
2022-03-01 -
2023-03-01
a year crt.sh
*.g.doubleclick.net
GTS CA 1C3
2022-09-05 -
2022-11-28
3 months crt.sh
moatads.com
DigiCert SHA2 Secure Server CA
2021-11-27 -
2022-11-29
a year crt.sh
www.cancernetwork.com
R3
2022-07-28 -
2022-10-26
3 months crt.sh
www.google.com
GTS CA 1C3
2022-08-29 -
2022-11-21
3 months crt.sh
www.google.de
GTS CA 1C3
2022-08-29 -
2022-11-21
3 months crt.sh
cmp.osano.com
Amazon
2022-09-02 -
2023-09-30
a year crt.sh
res.lassomarketing.io
GTS CA 1D4
2022-08-05 -
2022-11-03
3 months crt.sh
ssl1029400.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2022-06-01 -
2022-12-08
6 months crt.sh
*.s3.amazonaws.com
Amazon
2021-12-15 -
2022-12-03
a year crt.sh
*.sanity.io
Sectigo RSA Domain Validation Secure Server CA
2021-09-30 -
2022-10-31
a year crt.sh
*.segment.com
Amazon
2022-01-12 -
2023-02-10
a year crt.sh
*.hotjar.com
Amazon
2021-11-25 -
2022-12-23
a year crt.sh
*.js.ubembed.com
GlobalSign Atlas R3 DV TLS CA H2 2021
2022-01-04 -
2023-02-05
a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2022-07-01 -
2022-09-29
3 months crt.sh
s.adroll.com
Amazon
2022-07-03 -
2023-08-01
a year crt.sh
*.azurewebsites.net
Microsoft Azure TLS Issuing CA 01
2022-03-14 -
2023-03-09
a year crt.sh
assets.ubembed.com
Amazon
2022-02-04 -
2023-03-05
a year crt.sh
vtrk.doubleverify.com
Go Daddy Secure Certificate Authority - G2
2021-12-03 -
2023-01-04
a year crt.sh
adroll.mgr.consensu.org
Amazon
2022-08-10 -
2023-09-08
a year crt.sh
*.segment.io
Amazon
2022-02-10 -
2023-03-11
a year crt.sh
*.google.com
GTS CA 1C3
2022-08-29 -
2022-11-21
3 months crt.sh
*.google.de
GTS CA 1C3
2022-08-29 -
2022-11-21
3 months crt.sh
*.adnxs.com
GeoTrust ECC CA 2018
2022-02-11 -
2023-03-14
a year crt.sh
*.adsrvr.org
GlobalSign GCC R3 DV TLS CA 2020
2022-03-31 -
2023-05-02
a year crt.sh
vercel-insights.com
Amazon
2021-10-24 -
2022-11-21
a year crt.sh

This page contains 6 frames:

Primary Page: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Frame ID: AD8E64C7C221F426E6AEA55A861F6A44
Requests: 130 HTTP requests in this frame

Frame: https://s7.addthis.com/static/sh.f48a1a04fe8dbf021b4cda1d.html
Frame ID: 4BA51E1A32F9652C60D07D6DFB83E7F5
Requests: 1 HTTP requests in this frame

Frame: https://s7.addthis.com/static/sh.f48a1a04fe8dbf021b4cda1d.html
Frame ID: 7A7546DB6A41376D85E4AF739BABA439
Requests: 1 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/html/r20220915/r20190131/zrt_lookup.html
Frame ID: 5DAC0B827BD6E25E74757B8BCDD5AC04
Requests: 1 HTTP requests in this frame

Frame: https://vars.hotjar.com/box-69edcc3187336f9b0a3fbb4c73be9fe6.html
Frame ID: E7B2575835F29A23E514921B593AF7F0
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 7CC2AD0A1EB16DF4070954129A7C84E5
Requests: 1 HTTP requests in this frame

Screenshot

Page Title

Neoadjuvant Pegylated Lipsomal Doxorubicin/Cyclophosphamide Plus Trastuzumab/Pertuzumab Yields Promising Efficacy in HER2+ Breast Cancer

Page URL History Show full URLs

  1. https://u27622772.ct.sendgrid.net/ls/click?upn=mLRiRs4fGxEXMjgAuR5aaTG-2Fv2eHhn-2Bq6YGnhsdclwDS-2FcPOMoNjvjwrF... HTTP 302
    https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin Page URL
  2. https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastu... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • ubembed\.com

Overall confidence: 100%
Detected patterns
  • bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.js

Overall confidence: 100%
Detected patterns
  • (?:a|s)\.adroll\.com

Overall confidence: 100%
Detected patterns
  • addthis\.com/js/

Overall confidence: 100%
Detected patterns
  • adnxs\.(?:net|com)

Overall confidence: 100%
Detected patterns
  • //connect\.facebook\.([a-z]+)/[^/]*/[a-z]*\.js

Overall confidence: 100%
Detected patterns
  • (?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)

Overall confidence: 100%
Detected patterns
  • googlesyndication\.com/

Overall confidence: 100%
Detected patterns
  • google-analytics\.com/(?:ga|urchin|analytics)\.js

Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtm\.js
  • googletagmanager\.com/gtag/js

Overall confidence: 100%
Detected patterns
  • //static\.hotjar\.com/

Overall confidence: 100%
Detected patterns
  • lightbox(?:-plus-jquery)?.{0,32}\.js

Overall confidence: 100%
Detected patterns
  • snap\.licdn\.com/li\.lms-analytics/insight\.min\.js

Overall confidence: 100%
Detected patterns
  • moatads\.com

Overall confidence: 100%
Detected patterns
  • ([\d.]+)?/modernizr(?:\.([\d.]+))?.*\.js

Overall confidence: 100%
Detected patterns
  • cdn\.segment\.com/analytics\.js

Overall confidence: 100%
Detected patterns
  • jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

Page Statistics

135
Requests

93 %
HTTPS

48 %
IPv6

35
Domains

47
Subdomains

43
IPs

5
Countries

2799 kB
Transfer

9464 kB
Size

42
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://u27622772.ct.sendgrid.net/ls/click?upn=mLRiRs4fGxEXMjgAuR5aaTG-2Fv2eHhn-2Bq6YGnhsdclwDS-2FcPOMoNjvjwrFJh-2BwwLHc7iVTGL-2BK7l0ZjP4qhFsmuktOWaJYc3Yy51UXsG9h-2FNSim1wwcJKv5i2kL1ipTI1GBMaC091gO8fBzBTn5Cobw-3D-3DE89I_XAjbFZuehWRKjPyTBOa8FFFSrxxsnCdUsIg0jQBZN2xWu635a3zW6vfI0zau17X4cBIGf-2BeMuqhjb15fqyUDWrNl55chQDU0zjgkYlliUfJAIiX5ODuwaT6xF2brSDyQcptoUaJEObpamLHAFUTp65c21ly5pdT5CHO8C9icjuPaCeXcHvklQ1GmaWlgGTKdxt6-2B5KrFK3skImDS-2FYIxDeIh7At196uHBISlt-2FncaID1N-2F3dvvh24WAVdshqD4rqpgx3v9gkQEDSHxKpjWbfMX9ECjCgxSHVqCSp5UltHcQ-3D HTTP 302
    https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin Page URL
  2. https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 0
  • https://u27622772.ct.sendgrid.net/ls/click?upn=mLRiRs4fGxEXMjgAuR5aaTG-2Fv2eHhn-2Bq6YGnhsdclwDS-2FcPOMoNjvjwrFJh-2BwwLHc7iVTGL-2BK7l0ZjP4qhFsmuktOWaJYc3Yy51UXsG9h-2FNSim1wwcJKv5i2kL1ipTI1GBMaC091gO8fBzBTn5Cobw-3D-3DE89I_XAjbFZuehWRKjPyTBOa8FFFSrxxsnCdUsIg0jQBZN2xWu635a3zW6vfI0zau17X4cBIGf-2BeMuqhjb15fqyUDWrNl55chQDU0zjgkYlliUfJAIiX5ODuwaT6xF2brSDyQcptoUaJEObpamLHAFUTp65c21ly5pdT5CHO8C9icjuPaCeXcHvklQ1GmaWlgGTKdxt6-2B5KrFK3skImDS-2FYIxDeIh7At196uHBISlt-2FncaID1N-2F3dvvh24WAVdshqD4rqpgx3v9gkQEDSHxKpjWbfMX9ECjCgxSHVqCSp5UltHcQ-3D HTTP 302
  • https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Request Chain 34
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=3145841&time=1663795133305&url=https%3A%2F%2Fins1.caboodleai.net%2Fen%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin HTTP 302
  • https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D3145841%26time%3D1663795133305%26url%3Dhttps%253A%252F%252Fins1.caboodleai.net%252Fen%252Farticle%252F165823%252Fneoadjuvant-pegylated-lipsomal-doxorubicin%26liSync%3Dtrue HTTP 302
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=3145841&time=1663795133305&url=https%3A%2F%2Fins1.caboodleai.net%2Fen%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin&liSync=true HTTP 302
  • https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=3145841&time=1663795133305&url=https%3A%2F%2Fins1.caboodleai.net%2Fen%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin&liSync=true&e_ipv6=AQI2Bkow08V01gAAAYNh6v1UlG-0Gz1gvktd6d8P6b0NGV3X3CZRSFq9LGixUd6DC73Ue_UBmA
Request Chain 102
  • https://trc.lhmos.com/uid/set?mjhPubId=&mcode=28436&mid=582 HTTP 302
  • https://secure.adnxs.com/getuidu?https://trc.lhmos.com/uid/save/?uid=$UID&mjhPubId=&mcode=28436&mid=582 HTTP 307
  • https://secure.adnxs.com/bounce?%2Fgetuidu%3Fhttps%3A%2F%2Ftrc.lhmos.com%2Fuid%2Fsave%2F%3Fuid%3D%24UID%26mjhPubId%3D%26mcode%3D28436%26mid%3D582 HTTP 302
  • https://trc.lhmos.com/uid/save/?uid=853839932400296011&mjhPubId=&mcode=28436&mid=582 HTTP 302
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=v0gsn3b&ttd_tpi=1&ttd_puid=582&ttd_puid=null&ttd_puid=853839932400296011&ttd_puid=&ttd_puid=ec6fd4e3-ce97-4f29-b582-67026bc49faf
Request Chain 103
  • https://trc.lhmos.com/msmnt/?id=32860&cid=e896b993-9f71-44ac-962a-72b3eb82ed3d HTTP 302
  • https://secure.adnxs.com/getuidu?https://trc.lhmos.com/msmnt/save/?uid=$UID&id=32860&cid=e896b993-9f71-44ac-962a-72b3eb82ed3d HTTP 307
  • https://secure.adnxs.com/bounce?%2Fgetuidu%3Fhttps%3A%2F%2Ftrc.lhmos.com%2Fmsmnt%2Fsave%2F%3Fuid%3D%24UID%26id%3D32860%26cid%3De896b993-9f71-44ac-962a-72b3eb82ed3d HTTP 302
  • https://trc.lhmos.com/msmnt/save/?uid=853839932400296011&id=32860&cid=e896b993-9f71-44ac-962a-72b3eb82ed3d
Request Chain 110
  • https://s.adroll.com/j/exp/2UKVTUKDWZHOZHUORA7U2Z/index.js HTTP 302
  • https://s.adroll.com/j/exp/index.js

135 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
neoadjuvant-pegylated-lipsomal-doxorubicin
ins1.caboodleai.net/en/article/165823/
Redirect Chain
  • https://u27622772.ct.sendgrid.net/ls/click?upn=mLRiRs4fGxEXMjgAuR5aaTG-2Fv2eHhn-2Bq6YGnhsdclwDS-2FcPOMoNjvjwrFJh-2BwwLHc7iVTGL-2BK7l0ZjP4qhFsmuktOWaJYc3Yy51UXsG9h-2FNSim1wwcJKv5i2kL1ipTI1GBMaC091gO...
  • https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
30 KB
11 KB
Document
General
Full URL
https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.36.162.19 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-36-162-19.deploy.static.akamaitechnologies.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
ebb4310be8a1e03b277bc78005ff66c49ee546c62bb8d373b15f7f78ed3f4857

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

Cache-Control
private, max-age=7200, s-maxage=0
Connection
keep-alive
Content-Encoding
gzip
Content-Length
9513
Content-Type
text/html; charset=utf-8
Date
Wed, 21 Sep 2022 21:18:52 GMT
Server
Microsoft-IIS/10.0
Vary
Accept-Encoding
X-AspNet-Version
4.0.30319
X-AspNetMvc-Version
5.2
X-Powered-By
ASP.NET

Redirect headers

Connection
keep-alive
Content-Length
111
Content-Type
text/html; charset=utf-8
Date
Wed, 21 Sep 2022 21:18:51 GMT
Location
https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Server
nginx
X-Robots-Tag
noindex, nofollow
remote-article-details.less
ins1.caboodleai.net/Content/responsiveStyle/
292 KB
53 KB
Stylesheet
General
Full URL
https://ins1.caboodleai.net/Content/responsiveStyle/remote-article-details.less?v=1617960960-1762609683
Requested by
Host: ins1.caboodleai.net
URL: https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.36.162.19 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-36-162-19.deploy.static.akamaitechnologies.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
98c8d155b2ee4c887bcdc446135d70a43fa31603f7eee3fb935c7233d8638470

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

Date
Wed, 21 Sep 2022 21:18:52 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
text/css; charset=utf-8
Cache-Control
public, max-age=72321
Connection
keep-alive
Content-Length
53698
Expires
Thu, 22 Sep 2022 17:24:13 GMT
startup.js
ins1.caboodleai.net/scripts/
97 KB
35 KB
Script
General
Full URL
https://ins1.caboodleai.net/scripts/startup.js?v=SZIkTluuDDrbNNH8GM4-FpqV6Eys0GnR6vxcbHZZh7I1
Requested by
Host: ins1.caboodleai.net
URL: https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.36.162.19 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-36-162-19.deploy.static.akamaitechnologies.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
7f4d6285789a95df776bb0a1fc1201107b75dbe78cbaeb404f5b5d340fcefc09

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

Date
Wed, 21 Sep 2022 21:18:52 GMT
Content-Encoding
gzip
Last-Modified
Wed, 21 Sep 2022 17:08:32 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
text/javascript; charset=utf-8
Cache-Control
public, max-age=71391
Connection
keep-alive
Content-Length
35098
Expires
Thu, 22 Sep 2022 17:08:43 GMT
font-awesome.min.css
maxcdn.bootstrapcdn.com/font-awesome/4.2.0/css/
21 KB
5 KB
Stylesheet
General
Full URL
https://maxcdn.bootstrapcdn.com/font-awesome/4.2.0/css/font-awesome.min.css
Requested by
Host: ins1.caboodleai.net
URL: https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:bcf , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
0fb1bbca73646e8e2b93c82e8d8b219647b13d4b440c48e338290b9a685b8de1
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:52 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
cdn-edgestorageid
601, 718, 718, 718
age
12766700
cdn-cachedat
2021-04-25 21:52:22
cdn-pullzone
252412
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
timing-allow-origin
*
access-control-allow-origin
*
last-modified
Mon, 25 Jan 2021 22:04:53 GMT
server
cloudflare
cdn-requestpullcode
200
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/css; charset=utf-8
cdn-cache
HIT
vary
Accept-Encoding
cache-control
public, max-age=31919000
cdn-uid
b1941f61-b576-4f40-80de-5677acb38f74
cdn-requestid
9b7224f4303542138f102867544bce49
cf-ray
74e5d5fb8c78021d-ZRH
cdn-requestcountrycode
CH
cdn-requestpullsuccess
True
css
fonts.googleapis.com/
8 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Open+Sans:400,700,600
Requested by
Host: ins1.caboodleai.net
URL: https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
dda36ab0dda2b7ba616e824e0dd455eb222bf9fee24984c74e19df9fa962758e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Wed, 21 Sep 2022 21:18:52 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
date
Wed, 21 Sep 2022 21:18:52 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Wed, 21 Sep 2022 21:18:52 GMT
modernizr.js
ins1.caboodleai.net/scripts/
11 KB
5 KB
Script
General
Full URL
https://ins1.caboodleai.net/scripts/modernizr.js?v=inCVuEFe6J4Q07A0AcRsbJic_UE5MwpRMNGcOtk94TE1
Requested by
Host: ins1.caboodleai.net
URL: https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.36.162.19 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-36-162-19.deploy.static.akamaitechnologies.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
9e83216908224ffbc39992a5e60f93ca21b8e2240ba28025ba679c4b70f7112d

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

Date
Wed, 21 Sep 2022 21:18:52 GMT
Content-Encoding
gzip
Last-Modified
Wed, 21 Sep 2022 17:08:33 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
text/javascript; charset=utf-8
Cache-Control
public, max-age=71373
Connection
keep-alive
Content-Length
4503
Expires
Thu, 22 Sep 2022 17:08:25 GMT
main.js
ins1.caboodleai.net/scripts/
1 MB
394 KB
Script
General
Full URL
https://ins1.caboodleai.net/scripts/main.js?v=hzo-42zjy69F0gxOZPd765WQiIdmcHWS-RRVNNDq-hA1
Requested by
Host: ins1.caboodleai.net
URL: https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.36.162.19 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-36-162-19.deploy.static.akamaitechnologies.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
664c76e65bd287c6c8ed18189bd288e672703482528352b995fa398b9b001a06

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

Date
Wed, 21 Sep 2022 21:18:52 GMT
Content-Encoding
gzip
Last-Modified
Wed, 21 Sep 2022 17:08:33 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
text/javascript; charset=utf-8
Cache-Control
public, max-age=71341
Connection
keep-alive
Content-Length
402686
Expires
Thu, 22 Sep 2022 17:07:53 GMT
feed.js
ins1.caboodleai.net/scripts/
2 KB
1 KB
Script
General
Full URL
https://ins1.caboodleai.net/scripts/feed.js?v=bDvH3otD41WOEDvpWJ2h-pNveHey-P6t6zhMjVVRZLs1
Requested by
Host: ins1.caboodleai.net
URL: https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.36.162.19 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-36-162-19.deploy.static.akamaitechnologies.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
3be252a3c458dba4d7d04e3d6dafa8ce034f2d7318b6f9eb3557074d46579e80

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

Date
Wed, 21 Sep 2022 21:18:52 GMT
Content-Encoding
gzip
Last-Modified
Wed, 21 Sep 2022 17:08:31 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
text/javascript; charset=utf-8
Cache-Control
public, max-age=71274
Connection
keep-alive
Content-Length
1021
Expires
Thu, 22 Sep 2022 17:06:46 GMT
remotearticle.js
ins1.caboodleai.net/scripts/
651 B
696 B
Script
General
Full URL
https://ins1.caboodleai.net/scripts/remotearticle.js?v=GnvUn3_x-6wWVPKlW5S3TL-vZ3ch_q7-S1Ayyu37LNo1
Requested by
Host: ins1.caboodleai.net
URL: https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.36.162.19 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-36-162-19.deploy.static.akamaitechnologies.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
7e77bb2a841fa5913398a32de629621b5c9c1b9674d6f9622e4b2002761333a8

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

Date
Wed, 21 Sep 2022 21:18:52 GMT
Content-Encoding
gzip
Last-Modified
Wed, 21 Sep 2022 17:08:33 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
text/javascript; charset=utf-8
Cache-Control
public, max-age=71454
Connection
keep-alive
Content-Length
298
Expires
Thu, 22 Sep 2022 17:09:46 GMT
addthis_widget.js
s7.addthis.com/js/250/
353 KB
114 KB
Script
General
Full URL
https://s7.addthis.com/js/250/addthis_widget.js
Requested by
Host: ins1.caboodleai.net
URL: https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.75.88.126 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-75-88-126.deploy.static.akamaitechnologies.com
Software
nginx/1.15.8 /
Resource Hash
acd2f7ad78edeebad4b6b0fdd17ff57d81c3726c60fd5435ee8c5a0115d29403
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

strict-transport-security
max-age=15724800; includeSubDomains
content-encoding
gzip
last-modified
Mon, 26 Oct 2020 18:11:48 GMT
server
nginx/1.15.8
etag
"5f971164-5834c"
vary
Accept-Encoding
x-distribution
99
content-type
application/javascript
cache-control
public, max-age=600
date
Wed, 21 Sep 2022 21:18:53 GMT
x-host
s7.addthis.com
content-length
116421
gtm.js
www.googletagmanager.com/
195 KB
68 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-5VF5P92
Requested by
Host: ins1.caboodleai.net
URL: https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
5fb2cd600b2b3a2c564c5c9ab1a78b92d0cfa8657f77e1d88159ac3ea575f749
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:52 GMT
content-encoding
br
vary
Accept-Encoding
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
69506
x-xss-protection
0
last-modified
Wed, 21 Sep 2022 21:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Wed, 21 Sep 2022 21:18:52 GMT
analytics.js
www.google-analytics.com/
49 KB
20 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: ins1.caboodleai.net
URL: https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
9e25469f734732205f33dd80ff8ca12080406c18d2fa99a1f368103e51f7999f
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Sun, 11 Sep 2022 13:50:09 GMT
server
Golfe2
age
1012
date
Wed, 21 Sep 2022 21:02:00 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
19826
expires
Wed, 21 Sep 2022 23:02:00 GMT
memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2
fonts.gstatic.com/s/opensans/v34/
44 KB
44 KB
Font
General
Full URL
https://fonts.gstatic.com/s/opensans/v34/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Open+Sans:400,700,600
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
8778e9af2422858d7052ff9a0f3c12c08ae976bdd6e0316db144cd5579cd97db
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://ins1.caboodleai.net
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Mon, 19 Sep 2022 18:50:34 GMT
x-content-type-options
nosniff
age
181698
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
44856
x-xss-protection
0
last-modified
Mon, 15 Aug 2022 18:20:18 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 19 Sep 2023 18:50:34 GMT
logreadarticle
ins1.caboodleai.net/en/article/
0
415 B
XHR
General
Full URL
https://ins1.caboodleai.net/en/article/logreadarticle?articleId=165823&amp;tag=remoteArticleDetails
Requested by
Host: ins1.caboodleai.net
URL: https://ins1.caboodleai.net/scripts/startup.js?v=SZIkTluuDDrbNNH8GM4-FpqV6Eys0GnR6vxcbHZZh7I1
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
23.36.162.19 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a23-36-162-19.deploy.static.akamaitechnologies.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept
*/*
Referer
https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
X-XSRF-Token
QXvg4L93U7LHHKPXxqaday5xYQWJvYi6Zk58LHSZ4Xu0ZWIFmvBcCsMfDvEk1T3QXCQeZqUFXaZjRZCNYYhyvZJV-_41
X-Requested-With
XMLHttpRequest
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

Date
Wed, 21 Sep 2022 21:18:53 GMT
X-AspNetMvc-Version
5.2
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Cache-Control
private, max-age=7142
Connection
keep-alive
Content-Length
0
collect
www.google-analytics.com/j/
4 B
211 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j97&a=1545303638&t=pageview&_s=1&dl=https%3A%2F%2Fins1.caboodleai.net%2Fen%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin&ul=en-us&de=UTF-8&dt=INS%20-%20Neoadjuvant%20Pegylated%20Lipsomal%20Doxorubicin%2FCyclophosphamide%20Plus%20Trastuzumab%2FPertuzumab%20Yields%20Promising%20Efficacy%20in%20HER2%2B%20Breast%20Cancer&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=IEBAAEABAAAAAC~&jid=1325763468&gjid=638491242&cid=679651309.1663795133&uid=ins1-a-38622e25-c93d-47ce-9690-5a860c75cf25&tid=UA-54944096-1&_gid=1595459267.1663795133&_r=1&_slc=1&cd1=13468&cd2=ins1-a-38622e25-c93d-47ce-9690-5a860c75cf25&z=1375866753
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
aec60bc104db041b1512185839f18f52986df7e569e5445f740dd60f763fbca8
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://ins1.caboodleai.net/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:53 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://ins1.caboodleai.net
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
www.google-analytics.com/j/
4 B
69 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j97&a=1545303638&t=pageview&_s=1&dl=https%3A%2F%2Fins1.caboodleai.net%2Fen%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin&ul=en-us&de=UTF-8&dt=INS%20-%20Neoadjuvant%20Pegylated%20Lipsomal%20Doxorubicin%2FCyclophosphamide%20Plus%20Trastuzumab%2FPertuzumab%20Yields%20Promising%20Efficacy%20in%20HER2%2B%20Breast%20Cancer&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=IEDAAEABAAAAAC~&jid=1571674658&gjid=415686483&cid=679651309.1663795133&uid=ins1-a-38622e25-c93d-47ce-9690-5a860c75cf25&tid=UA-48352660-1&_gid=1595459267.1663795133&_r=1&_slc=1&cd1=13468&cd2=ins1-a-38622e25-c93d-47ce-9690-5a860c75cf25&z=853757072
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
aec60bc104db041b1512185839f18f52986df7e569e5445f740dd60f763fbca8
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://ins1.caboodleai.net/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:53 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://ins1.caboodleai.net
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
www.google-analytics.com/j/
2 B
22 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j97&a=1545303638&t=pageview&_s=1&dl=https%3A%2F%2Fins1.caboodleai.net%2Fen%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin&ul=en-us&de=UTF-8&dt=INS%20-%20Neoadjuvant%20Pegylated%20Lipsomal%20Doxorubicin%2FCyclophosphamide%20Plus%20Trastuzumab%2FPertuzumab%20Yields%20Promising%20Efficacy%20in%20HER2%2B%20Breast%20Cancer&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=aGDACEABBAAAAC~&jid=840415780&gjid=1468987937&cid=679651309.1663795133&tid=UA-168107088-1&_gid=1595459267.1663795133&_r=1&cd1=ins1&cd2=ins1-a-38622e25-c93d-47ce-9690-5a860c75cf25&gtm=2wg9j05VF5P92&cd3=13468&z=112165346
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
de3246094525b21a870fc7d2a67490d0132535c6fa5993755c549f1a9d1bd8af
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://ins1.caboodleai.net/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:53 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://ins1.caboodleai.net
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2
expires
Fri, 01 Jan 1990 00:00:00 GMT
analytics_debug.js
www.google-analytics.com/u/
63 KB
25 KB
Script
General
Full URL
https://www.google-analytics.com/u/analytics_debug.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5VF5P92
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 19:37:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Sun, 11 Sep 2022 13:50:09 GMT
server
Golfe2
age
6066
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
25173
expires
Wed, 21 Sep 2022 21:37:47 GMT
insight.min.js
snap.licdn.com/li.lms-analytics/
8 KB
3 KB
Script
General
Full URL
https://snap.licdn.com/li.lms-analytics/insight.min.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5VF5P92
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:11a::6867:4868 Vienna, Austria, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:53 GMT
content-encoding
gzip
last-modified
Fri, 12 Aug 2022 20:23:36 GMT
x-cdn
AKAM
vary
Accept-Encoding
content-type
application/x-javascript;charset=utf-8
cache-control
max-age=70993
accept-ranges
bytes
content-length
3063
js
www.googletagmanager.com/gtag/
207 KB
73 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-RYRWC30G4W&l=dataLayer&cx=c
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5VF5P92
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:831::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:53 GMT
content-encoding
br
server
Google Tag Manager
access-control-allow-headers
Cache-Control
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; includeSubDomains
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
74598
x-xss-protection
0
expires
Wed, 21 Sep 2022 21:18:53 GMT
js
www.googletagmanager.com/gtag/
210 KB
73 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-1J5889RZEV&l=dataLayer&cx=c
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5VF5P92
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:831::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:53 GMT
content-encoding
br
server
Google Tag Manager
access-control-allow-headers
Cache-Control
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; includeSubDomains
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
75215
x-xss-protection
0
expires
Wed, 21 Sep 2022 21:18:53 GMT
collect
stats.g.doubleclick.net/j/
1 B
441 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j97&tid=UA-54944096-1&cid=679651309.1663795133&jid=1325763468&uid=ins1-a-38622e25-c93d-47ce-9690-5a860c75cf25&gjid=638491242&_gid=1595459267.1663795133&_u=IEBAAEAAAAAAAC~&z=540655762
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c08::9a Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://ins1.caboodleai.net/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
date
Wed, 21 Sep 2022 21:18:53 GMT
content-type
text/plain
access-control-allow-origin
https://ins1.caboodleai.net
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
stats.g.doubleclick.net/j/
1 B
67 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j97&tid=UA-48352660-1&cid=679651309.1663795133&jid=1571674658&uid=ins1-a-38622e25-c93d-47ce-9690-5a860c75cf25&gjid=415686483&_gid=1595459267.1663795133&_u=IEDAAEABAAAAAC~&z=427421112
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c08::9a Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://ins1.caboodleai.net/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
date
Wed, 21 Sep 2022 21:18:53 GMT
content-type
text/plain
access-control-allow-origin
https://ins1.caboodleai.net
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1
expires
Fri, 01 Jan 1990 00:00:00 GMT
moatframe.js
z.moatads.com/addthismoatframe568911941483/
2 KB
1 KB
Script
General
Full URL
https://z.moatads.com/addthismoatframe568911941483/moatframe.js
Requested by
Host: s7.addthis.com
URL: https://s7.addthis.com/js/250/addthis_widget.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.35.237.151 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-35-237-151.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

unused62
8096267
date
Wed, 21 Sep 2022 21:18:53 GMT
content-encoding
gzip
last-modified
Fri, 08 Nov 2019 20:13:52 GMT
server
AmazonS3
x-amz-request-id
D5503D14AA2F06AA
etag
"f14b4e1f799b14f798a195f43cf58376"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
max-age=55483
accept-ranges
bytes
content-length
948
x-amz-id-2
JgalEtxvSAtZmM7+naGfrhsdf0JFS0gJW8lypWF8Tp90EkcPp4c3eAnpK+RDOIL1ltWgpx8wc3s=
collect
stats.g.doubleclick.net/j/
4 B
72 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j97&tid=UA-168107088-1&cid=679651309.1663795133&jid=840415780&gjid=1468987937&_gid=1595459267.1663795133&_u=aGDACEABBAAAAC~&z=382999526
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c08::9a Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://ins1.caboodleai.net/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
date
Wed, 21 Sep 2022 21:18:53 GMT
content-type
text/plain
access-control-allow-origin
https://ins1.caboodleai.net
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
_ate.track.config_resp
v1.addthisedge.com/live/boost/ra-5f4f5c0b0070a69b/
2 KB
804 B
Script
General
Full URL
https://v1.addthisedge.com/live/boost/ra-5f4f5c0b0070a69b/_ate.track.config_resp
Requested by
Host: s7.addthis.com
URL: https://s7.addthis.com/js/250/addthis_widget.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.75.88.126 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-75-88-126.deploy.static.akamaitechnologies.com
Software
/
Resource Hash

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:53 GMT
content-encoding
gzip
etag
1181152890--gzip
vary
Accept-Encoding
content-type
application/javascript;charset=utf-8
cache-control
public, max-age=31, s-maxage=86400
content-disposition
attachment; filename=1.txt
content-length
628
300lo.json
m.addthis.com/live/red_lojson/
91 B
251 B
Script
General
Full URL
https://m.addthis.com/live/red_lojson/300lo.json?si=632b7fbdbbf615c9&bkl=0&bl=1&pdt=1146&sid=632b7fbdbbf615c9&pub=ra-5f4f5c0b0070a69b&rev=v8.28.8-wp&ln=en&pc=men&cb=0&ab=-&dp=www.cancernetwork.com&fp=view%2Fneoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer&fr=&of=0&pd=0&irt=0&vcl=0&md=0&ct=1&tct=0&abt=0&cdn=0&pi=1&rb=0&gen=100&chr=UTF-8&colc=1663795133242&jsl=1&uvs=632b7fbd50c46c55000&skipb=1&callback=addthis.cbs.jsonp__0536637402019297660
Requested by
Host: s7.addthis.com
URL: https://s7.addthis.com/js/250/addthis_widget.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.75.88.126 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-75-88-126.deploy.static.akamaitechnologies.com
Software
/
Resource Hash

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:53 GMT
cache-control
max-age=0, no-cache, no-store, no-transform
content-disposition
attachment; filename=1.txt
content-length
91
content-type
application/javascript;charset=utf-8
sh.f48a1a04fe8dbf021b4cda1d.html
s7.addthis.com/static/ Frame 4BA5
0
0

sh.f48a1a04fe8dbf021b4cda1d.html
s7.addthis.com/static/ Frame 7A75
71 KB
26 KB
Document
General
Full URL
https://s7.addthis.com/static/sh.f48a1a04fe8dbf021b4cda1d.html
Requested by
Host: s7.addthis.com
URL: https://s7.addthis.com/js/250/addthis_widget.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.75.88.126 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-75-88-126.deploy.static.akamaitechnologies.com
Software
nginx/1.15.8 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://ins1.caboodleai.net/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

cache-control
public, max-age=86313600
content-encoding
gzip
content-length
26421
content-type
text/html
date
Wed, 21 Sep 2022 21:18:53 GMT
etag
W/"5f971164-11adc"
last-modified
Mon, 26 Oct 2020 18:11:48 GMT
p3p
CP="NON ADM OUR DEV IND COM STA"
server
nginx/1.15.8
strict-transport-security
max-age=15724800; includeSubDomains
timing-allow-origin
*
vary
Accept-Encoding
x-host
s7.addthis.com
Primary Request neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
www.cancernetwork.com/view/
146 KB
31 KB
Document
General
Full URL
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Requested by
Host: ins1.caboodleai.net
URL: https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel / Next.js
Resource Hash
ae549167ef2e43019e58d4e8c3f9874b9647abf0aa042c1062f39d36559fbb69
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

Referer
https://ins1.caboodleai.net/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

age
0
cache-control
private, no-cache, no-store, max-age=0, must-revalidate
content-encoding
br
content-type
text/html; charset=utf-8
date
Wed, 21 Sep 2022 21:18:54 GMT
etag
W/"248a8-etRA68eNPxd3qcdFdxHSU1c6ayU"
server
Vercel
strict-transport-security
max-age=63072000
x-matched-path
/view/[url]
x-powered-by
Next.js
x-vercel-cache
MISS
x-vercel-id
fra1::sfo1::5nbd5-1663795133900-2a286be0484f
ga-audiences
www.google.com/ads/
42 B
501 B
Image
General
Full URL
https://www.google.com/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j97&tid=UA-168107088-1&cid=679651309.1663795133&jid=840415780&_u=aGDACEABBAAAAC~&z=1700084807
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:829::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:53 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
42 B
107 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j97&tid=UA-168107088-1&cid=679651309.1663795133&jid=840415780&_u=aGDACEABBAAAAC~&z=1700084807
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82f::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:53 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
region1.analytics.google.com/g/
0
349 B
Ping
General
Full URL
https://region1.analytics.google.com/g/collect?v=2&tid=G-RYRWC30G4W&gtm=2oe9j0&_p=1545303638&_gaz=1&cid=679651309.1663795133&ul=en-us&sr=1600x1200&_z=ccd.v9B&_s=1&sid=1663795133&sct=1&seg=0&dl=https%3A%2F%2Fins1.caboodleai.net%2Fen%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin&dt=INS%20-%20Neoadjuvant%20Pegylated%20Lipsomal%20Doxorubicin%2FCyclophosphamide%20Plus%20Trastuzumab%2FPertuzumab%20Yields%20Promising%20Efficacy%20in%20HER2%2B%20Breast%20Cancer&en=page_view&_fv=1&_ss=1
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-RYRWC30G4W&l=dataLayer&cx=c
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:32::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:53 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://ins1.caboodleai.net
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
stats.g.doubleclick.net/g/
0
17 B
Ping
General
Full URL
https://stats.g.doubleclick.net/g/collect?v=2&tid=G-RYRWC30G4W&cid=679651309.1663795133&gtm=2oe9j0&aip=1
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-RYRWC30G4W&l=dataLayer&cx=c
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:400c:c08::9a Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:53 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://ins1.caboodleai.net
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
42 B
501 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&t=sr&slf_rd=1&_r=4&tid=G-RYRWC30G4W&cid=679651309.1663795133&gtm=2oe9j0&aip=1&z=439442853
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82f::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:53 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
px4.ads.linkedin.com/
Redirect Chain
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=3145841&time=1663795133305&url=https%3A%2F%2Fins1.caboodleai.net%2Fen%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin
  • https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D3145841%26time%3D1663795133305%26url%3Dhttps%253A%252F%252Fins1.caboodleai.net%25...
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=3145841&time=1663795133305&url=https%3A%2F%2Fins1.caboodleai.net%2Fen%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin&liSync=true
  • https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=3145841&time=1663795133305&url=https%3A%2F%2Fins1.caboodleai.net%2Fen%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin&liSync=true...
0
480 B
Image
General
Full URL
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=3145841&time=1663795133305&url=https%3A%2F%2Fins1.caboodleai.net%2Fen%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin&liSync=true&e_ipv6=AQI2Bkow08V01gAAAYNh6v1UlG-0Gz1gvktd6d8P6b0NGV3X3CZRSFq9LGixUd6DC73Ue_UBmA
Protocol
H2
Server
13.107.42.14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:53 GMT
nel
{"report_to":"network-errors","max_age":1296000,"success_fraction":0.00066,"failure_fraction":1,"include_subdomains":true}
x-li-pop
afd-prod-ltx1-x
x-msedge-ref
Ref A: 9E80CF296208493E9BD0677B9A502A88 Ref B: FRAEDGE1217 Ref C: 2022-09-21T21:18:53Z
linkedin-action
1
report-to
{"group":"network-errors","max_age":2592000,"endpoints":[{"url":"https://www.linkedin.com/li/rep"}],"include_subdomains":true}
content-type
application/javascript
x-li-proto
http/2
x-cache
CONFIG_NOCACHE
content-length
0
x-li-uuid
AAXpNn3wYTAvGUHYMbU04Q==
x-li-fabric
prod-ltx1

Redirect headers

date
Wed, 21 Sep 2022 21:18:53 GMT
nel
{"report_to":"network-errors","max_age":1296000,"success_fraction":0.00066,"failure_fraction":1,"include_subdomains":true}
x-li-pop
afd-prod-ltx1-x
x-msedge-ref
Ref A: 8E26DE568A9F4836A8CD20FF6C2FB0B1 Ref B: FRAEDGE1115 Ref C: 2022-09-21T21:18:53Z
linkedin-action
1
report-to
{"group":"network-errors","max_age":2592000,"endpoints":[{"url":"https://www.linkedin.com/li/rep"}],"include_subdomains":true}
x-li-fabric
prod-ltx1
location
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=3145841&time=1663795133305&url=https%3A%2F%2Fins1.caboodleai.net%2Fen%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin&liSync=true&e_ipv6=AQI2Bkow08V01gAAAYNh6v1UlG-0Gz1gvktd6d8P6b0NGV3X3CZRSFq9LGixUd6DC73Ue_UBmA
x-li-proto
http/2
x-cache
CONFIG_NOCACHE
content-length
0
x-li-uuid
AAXpNn3tRLirld5Hqcuj+Q==
collect
region1.google-analytics.com/g/
0
349 B
Ping
General
Full URL
https://region1.google-analytics.com/g/collect?v=2&tid=G-1J5889RZEV&gtm=2oe9j0&_p=1545303638&cid=679651309.1663795133&ul=en-us&sr=1600x1200&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&_z=ccd.v9B&_s=1&sid=1663795133&sct=1&seg=0&dl=https%3A%2F%2Fins1.caboodleai.net%2Fen%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin&dt=INS%20-%20Neoadjuvant%20Pegylated%20Lipsomal%20Doxorubicin%2FCyclophosphamide%20Plus%20Trastuzumab%2FPertuzumab%20Yields%20Promising%20Efficacy%20in%20HER2%2B%20Breast%20Cancer&en=page_view&_fv=1&_ss=1&up.siteNameId=ins1
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-1J5889RZEV&l=dataLayer&cx=c
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:34::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:53 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://ins1.caboodleai.net
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
layers.fa6cd1947ce26e890d3d.js
s7.addthis.com/static/
263 KB
76 KB
Script
General
Full URL
https://s7.addthis.com/static/layers.fa6cd1947ce26e890d3d.js
Requested by
Host: s7.addthis.com
URL: https://s7.addthis.com/js/250/addthis_widget.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.75.88.126 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-75-88-126.deploy.static.akamaitechnologies.com
Software
nginx/1.15.8 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ins1.caboodleai.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

strict-transport-security
max-age=15724800; includeSubDomains
content-encoding
gzip
last-modified
Mon, 26 Oct 2020 18:11:48 GMT
server
nginx/1.15.8
etag
W/"5f971164-41cf5"
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=86313600
date
Wed, 21 Sep 2022 21:18:53 GMT
x-host
s7.addthis.com
timing-allow-origin
*
content-length
77617
collect
region1.analytics.google.com/g/
0
0

collect
region1.google-analytics.com/g/
0
0

100eng.json
m.addthis.com/live/red_lojson/
0
0

osano.js
cmp.osano.com/6olh2SicG0V81Mlk/4710ecb0-531a-450d-8804-158efa200b4a/
218 KB
53 KB
Script
General
Full URL
https://cmp.osano.com/6olh2SicG0V81Mlk/4710ecb0-531a-450d-8804-158efa200b4a/osano.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:223c:f200:3:b7e:8940:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
CloudFront /
Resource Hash
64a6c1c3db90c284d35d86f4c382245a3abcb294563e5968be37a03751794106
Security Headers
Name Value
Strict-Transport-Security max-age=2592000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

strict-transport-security
max-age=2592000
content-encoding
br
x-content-type-options
nosniff
age
21853
x-cache
Hit from cloudfront
content-length
53497
x-xss-protection
mode=block
last-modified
Thu, 23 Sep 2021 09:03:24 GMT
server
CloudFront
date
Wed, 21 Sep 2022 15:14:42 GMT
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
via
1.1 03ffca0f67e3596b9a0c92342fe91598.cloudfront.net (CloudFront)
cache-control
public, max-age=86400, s-maxage=86400, must-revalidate, proxy-revalidate, no-transform
etag
"d5e868fb0ad03112c1a4a7c0c97ddd16"
x-amz-cf-pop
FRA56-P2
x-amz-cf-id
7EayhjjP-XjZsu8tOkbJG25cd94GFdKt_cUh7glFLcapBxE64XYMgg==
lasso-imp-id-min.js
res.lassomarketing.io/scripts/
1 KB
2 KB
Script
General
Full URL
https://res.lassomarketing.io/scripts/lasso-imp-id-min.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.182.184 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
184.182.244.35.bc.googleusercontent.com
Software
UploadServer /
Resource Hash
d75d72c8491fe13d0210b3f747f46ebb3bb248279e9f5ab2c40fdc7c120d6e94

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
age
0
x-guploader-uploadid
ADPycduiYb2lyKP2qXuHHDztg2iZwX6s2pHAt9OcVftOQ5eHcwAZ_YpRNbBZzaKAnk-AZAlg2LzuEb7EbOl_BZPkdHrbZA
x-goog-storage-class
STANDARD
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1252
last-modified
Tue, 30 Aug 2022 16:45:07 GMT
server
UploadServer
etag
"869612a39a7a7de72f1a51a949751c49"
x-goog-hash
crc32c=OMDKOw==, md5=hpYSo5p6fecvGlGpSXUcSQ==
x-goog-generation
1661877907178386
access-control-allow-origin
*
cache-control
no-cache,max-age=0
x-goog-stored-content-length
1252
accept-ranges
bytes
content-type
application/javascript
expires
Wed, 21 Sep 2022 21:18:55 GMT
lightbox_mjh.js
www.lightboxcdn.com/static/
5 KB
3 KB
Script
General
Full URL
https://www.lightboxcdn.com/static/lightbox_mjh.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2606:4700::6810:50a5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
244de2849ff5effe874d220c6920b3ac2d5d8019f521037a37525c563b32e8c6

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
cf-cache-status
HIT
content-md5
CWjngzvv7hFY+aIre9drWw==
age
25180
cf-polished
origSize=5632
x-ms-meta-cbmodifiedtime
Tue, 12 Jul 2022 23:53:00 GMT
last-modified
Wed, 20 Jul 2022 14:07:08 GMT
x-ms-lease-status
unlocked
cf-bgj
minify
server
cloudflare
vary
Accept-Encoding
content-type
application/x-javascript
x-ms-request-id
650e12b6-701e-0024-4942-9c817e000000
cache-control
public, max-age=31536000
x-ms-version
2009-09-19
cf-ray
74e5d60b8b0e0229-ZRH
expires
Thu, 21 Sep 2023 21:18:55 GMT
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/
167 KB
57 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:830::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
8391b947d3af4fbebaed9ed32ec99db7f43b7a8336fde277eaa2ae1629c797eb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
58013
x-xss-protection
0
server
cafe
etag
630915548426005144
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=3600
timing-allow-origin
*
expires
Wed, 21 Sep 2022 21:18:55 GMT
5384257999458475.css
www.cancernetwork.com/_next/static/css/
173 KB
32 KB
Stylesheet
General
Full URL
https://www.cancernetwork.com/_next/static/css/5384257999458475.css
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
ef007a513c7d1c5019a27d62c5fa3413656a6414e51660422f27bf10b0cab84d
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
94836
x-matched-path
/_next/static/css/5384257999458475.css
etag
W/"3787974846d74632600da0fffcbdeba7"
strict-transport-security
max-age=63072000
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::lth7n-1663795135160-b1b98a53788d
content-disposition
inline; filename="5384257999458475.css"
x-vercel-cache
HIT
203fb9bda5c213fb.css
www.cancernetwork.com/_next/static/css/
937 B
1 KB
Stylesheet
General
Full URL
https://www.cancernetwork.com/_next/static/css/203fb9bda5c213fb.css
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
5b31d7b87e269f44bc9c6e66dd1d6bf2f40f2b91a1314cbe21bb84a36d0f1b68
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
server
Vercel
age
94836
x-matched-path
/_next/static/css/203fb9bda5c213fb.css
etag
"0d827afb0adb231d65cb4928af095311"
strict-transport-security
max-age=63072000
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::2zq9d-1663795135159-a24269e5e34b
content-disposition
inline; filename="203fb9bda5c213fb.css"
accept-ranges
bytes
x-vercel-cache
HIT
content-length
937
webpack-5bc3c02718d096b9.js
www.cancernetwork.com/_next/static/chunks/
2 KB
1 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/webpack-5bc3c02718d096b9.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
d08edd63c00d47fd0777e717e1d4583d97c4a684245f87fd1e91bd7f1e0f428b
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
68515
x-matched-path
/_next/static/chunks/webpack-5bc3c02718d096b9.js
etag
W/"bb65599c0c07eeea537b1ec00284facf"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::5nbd5-1663795135343-2c806c900a77
content-disposition
inline; filename="webpack-5bc3c02718d096b9.js"
x-vercel-cache
HIT
framework-09f3afa64952aba4.js
www.cancernetwork.com/_next/static/chunks/
146 KB
48 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/framework-09f3afa64952aba4.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
90a9ae3e06adde637f610ff1371192aeadae1d9051a092e93f324ab95778ea33
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
65701
x-matched-path
/_next/static/chunks/framework-09f3afa64952aba4.js
etag
W/"d67fe5c1209fa9b7f84cf381eaeb1b4e"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::5nbd5-1663795135358-ced4d431b1a6
content-disposition
inline; filename="framework-09f3afa64952aba4.js"
x-vercel-cache
HIT
main-199da08254673e78.js
www.cancernetwork.com/_next/static/chunks/
184 KB
57 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/main-199da08254673e78.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
42713036ca5c6ef66f3d205b827dfa1ed884bd0f4c0b1d5fa52c259b8957ab54
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
63715
x-matched-path
/_next/static/chunks/main-199da08254673e78.js
etag
W/"2ee5a7e1a6fa88545a8f9ab6da46007c"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::lth7n-1663795135360-9307fdd47738
content-disposition
inline; filename="main-199da08254673e78.js"
x-vercel-cache
HIT
_app-629c8d5068702e80.js
www.cancernetwork.com/_next/static/chunks/pages/
447 KB
138 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/pages/_app-629c8d5068702e80.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
ae187a7bdae6e9f17b9ecc6fcd91a51e2e0c48d1776188064edfd119ac9d8177
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
84908
x-matched-path
/_next/static/chunks/pages/_app-629c8d5068702e80.js
etag
W/"4fa9605f035abc5b32cd229b6996d759"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::gqm82-1663795135360-59e5214112be
content-disposition
inline; filename="_app-629c8d5068702e80.js"
x-vercel-cache
HIT
d7eeaac4-d82f10b98e851281.js
www.cancernetwork.com/_next/static/chunks/
1 KB
616 B
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/d7eeaac4-d82f10b98e851281.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
ad380a37653ca56006070f0279da2ef726318b5bf99f8069449d8edc0439166b
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
74787
x-matched-path
/_next/static/chunks/d7eeaac4-d82f10b98e851281.js
etag
W/"94d8870423331184c9d7e04db91be1d4"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::x7mmg-1663795135360-9594b45f5d40
content-disposition
inline; filename="d7eeaac4-d82f10b98e851281.js"
x-vercel-cache
HIT
ee7c6489-4f5724fce7111193.js
www.cancernetwork.com/_next/static/chunks/
59 KB
20 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/ee7c6489-4f5724fce7111193.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
08ce75934a60623ed7afce900c892ff09712c8bab5d7ef6c48830748b61bd90c
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
94836
x-matched-path
/_next/static/chunks/ee7c6489-4f5724fce7111193.js
etag
W/"e9afa6e64745e403f832c7e640360e00"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::2zq9d-1663795135374-53931fac64f0
content-disposition
inline; filename="ee7c6489-4f5724fce7111193.js"
x-vercel-cache
HIT
1bfc9850-e4ff50856accae5e.js
www.cancernetwork.com/_next/static/chunks/
2 KB
1 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/1bfc9850-e4ff50856accae5e.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
b66e48a68d0828a03031d342f6ff41c9888bdca8bf594dc05b91e5d54d7259b6
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
61246
x-matched-path
/_next/static/chunks/1bfc9850-e4ff50856accae5e.js
etag
W/"31a5934ec66bf67a2b048d5c7683d9ed"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::2r9pj-1663795135362-8315ca4d2f29
content-disposition
inline; filename="1bfc9850-e4ff50856accae5e.js"
x-vercel-cache
HIT
e4627e50-2604714e9f8bf816.js
www.cancernetwork.com/_next/static/chunks/
214 KB
46 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/e4627e50-2604714e9f8bf816.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
41c92be57defe929019543beed19864e338c49494c5926c14a094021026744c1
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
69028
x-matched-path
/_next/static/chunks/e4627e50-2604714e9f8bf816.js
etag
W/"f7816943f336a4120c7afda6dd5a9270"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::tkml2-1663795135361-d3367dd5ee07
content-disposition
inline; filename="e4627e50-2604714e9f8bf816.js"
x-vercel-cache
HIT
9949-760b3f030a6c835f.js
www.cancernetwork.com/_next/static/chunks/
13 KB
5 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/9949-760b3f030a6c835f.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
b2f8f1ff372ffe802c4af0512bc6a6e7ecbd27548ac2d8ea7bb465f45b9c470b
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
60376
x-matched-path
/_next/static/chunks/9949-760b3f030a6c835f.js
etag
W/"f307d6e8b080190a5a40380d7b6881b2"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::r7chv-1663795135361-e34fd6b403fc
content-disposition
inline; filename="9949-760b3f030a6c835f.js"
x-vercel-cache
HIT
8186-59b6206aea75e822.js
www.cancernetwork.com/_next/static/chunks/
24 KB
9 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/8186-59b6206aea75e822.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
a0e061fcb058418dd1f5e931707cd37aceeed877fcae25766c43426d36d6903d
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
80279
x-matched-path
/_next/static/chunks/8186-59b6206aea75e822.js
etag
W/"1885533f3b0ab5cff7fa394d9862f3ac"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::gqm82-1663795135361-cbeb2b2a7e3c
content-disposition
inline; filename="8186-59b6206aea75e822.js"
x-vercel-cache
HIT
8648-e980744a480c99ce.js
www.cancernetwork.com/_next/static/chunks/
241 KB
72 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/8648-e980744a480c99ce.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
4cd895241257c20165b479591104acd17956489c2d7de88fb72746de411434b0
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
94836
x-matched-path
/_next/static/chunks/8648-e980744a480c99ce.js
etag
W/"7c6c7f3b81486c33bf9bad359a0e61fc"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::6xp7c-1663795135361-1381970b8f88
content-disposition
inline; filename="8648-e980744a480c99ce.js"
x-vercel-cache
HIT
1598-d6dbc31b59623278.js
www.cancernetwork.com/_next/static/chunks/
31 KB
13 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/1598-d6dbc31b59623278.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
e184d6f703b75965543d91688c705698861b1376fa25f23a5cdbe7b8f66e63f3
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
94836
x-matched-path
/_next/static/chunks/1598-d6dbc31b59623278.js
etag
W/"139834e1cbefabde54a6607a775b3b8a"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::6xp7c-1663795135376-d1acf8be5840
content-disposition
inline; filename="1598-d6dbc31b59623278.js"
x-vercel-cache
HIT
6147-4a499ebb381f1062.js
www.cancernetwork.com/_next/static/chunks/
8 KB
3 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/6147-4a499ebb381f1062.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
fdba01e144ba54810ca72aa9704485a14abcd89201985b561c49b1618ee4acad
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
81076
x-matched-path
/_next/static/chunks/6147-4a499ebb381f1062.js
etag
W/"b333d58d92587697ee82b82bc85973c5"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::lth7n-1663795135376-e1bb0daf69f8
content-disposition
inline; filename="6147-4a499ebb381f1062.js"
x-vercel-cache
HIT
3600-0ed0468a1b9f30d5.js
www.cancernetwork.com/_next/static/chunks/
11 KB
4 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/3600-0ed0468a1b9f30d5.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
c6881d5ada5d5d8707ea8687226606fffce4f632cbab34baf392f0cb73b5436b
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
86146
x-matched-path
/_next/static/chunks/3600-0ed0468a1b9f30d5.js
etag
W/"6ec3eb7c2b517e97f9f5da29f9e01bc6"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::tkml2-1663795135376-17cc1d78d3da
content-disposition
inline; filename="3600-0ed0468a1b9f30d5.js"
x-vercel-cache
HIT
3679-b59893dcf42f9b67.js
www.cancernetwork.com/_next/static/chunks/
10 KB
4 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/3679-b59893dcf42f9b67.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
b6ea52603aaaf6b4fa819f1ae9019bf500468131fa8f4e44305f9683309f9e84
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
52113
x-matched-path
/_next/static/chunks/3679-b59893dcf42f9b67.js
etag
W/"50d111f09676f212d2fcc9a668687142"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::r7chv-1663795135376-44ab0e0f8be3
content-disposition
inline; filename="3679-b59893dcf42f9b67.js"
x-vercel-cache
HIT
2946-7663e5c062e5fb6e.js
www.cancernetwork.com/_next/static/chunks/
8 KB
3 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/2946-7663e5c062e5fb6e.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
55de8fe308830545a7ea4f837f6b9f0b3d6e5afbf9fe351f316484c715176141
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
51133
x-matched-path
/_next/static/chunks/2946-7663e5c062e5fb6e.js
etag
W/"a30fa07ea8fdc81f0038a1e10cd3b1ea"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::x7mmg-1663795135376-fd55e437dfd9
content-disposition
inline; filename="2946-7663e5c062e5fb6e.js"
x-vercel-cache
HIT
1553-ef90f541254595ea.js
www.cancernetwork.com/_next/static/chunks/
101 KB
36 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/1553-ef90f541254595ea.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
5d39c4065e4526981e9e4ac4a21a840e10d57d2d336abc5d6b3976a983165e1e
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
94836
x-matched-path
/_next/static/chunks/1553-ef90f541254595ea.js
etag
W/"2d32c63aff1e9905b23a894d9dd1ec07"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::5nbd5-1663795135376-2d958254bee1
content-disposition
inline; filename="1553-ef90f541254595ea.js"
x-vercel-cache
HIT
1145-7bbf3e28b00c4b21.js
www.cancernetwork.com/_next/static/chunks/
57 KB
11 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/1145-7bbf3e28b00c4b21.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
38748c405369b6286c3e5385c5f95ee20704f398ef1afe7cbe7c28de7fbec30d
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
94836
x-matched-path
/_next/static/chunks/1145-7bbf3e28b00c4b21.js
etag
W/"2126ce1d3ba63a70a87f75bbb8cc0590"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::7np9k-1663795135376-c763b65eaf6b
content-disposition
inline; filename="1145-7bbf3e28b00c4b21.js"
x-vercel-cache
HIT
5227-d31c0f331fbc34a6.js
www.cancernetwork.com/_next/static/chunks/
134 KB
33 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/5227-d31c0f331fbc34a6.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
269aedd08bf7bb55f54bc040553bb7a8fa82d4bf511f6f9905122c965dda8115
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
94836
x-matched-path
/_next/static/chunks/5227-d31c0f331fbc34a6.js
etag
W/"ad03cb303973118620bd0f37a6ff13c0"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::gqm82-1663795135376-82366498a073
content-disposition
inline; filename="5227-d31c0f331fbc34a6.js"
x-vercel-cache
HIT
8633-3cca8203f7dd6354.js
www.cancernetwork.com/_next/static/chunks/
21 KB
7 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/8633-3cca8203f7dd6354.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
da67d3a3dd7576d85d617f642cf8356992c5af5eb41cbbb7e049c121f534f9c2
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
51200
x-matched-path
/_next/static/chunks/8633-3cca8203f7dd6354.js
etag
W/"6beebe818f6e0dbbad221d93502b7dd4"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::5gdf4-1663795135376-2b4f5873acf8
content-disposition
inline; filename="8633-3cca8203f7dd6354.js"
x-vercel-cache
HIT
2309-c457ee4517200742.js
www.cancernetwork.com/_next/static/chunks/
12 KB
4 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/2309-c457ee4517200742.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
89ab81ca7e3e2d2e7e166ccbc0b3de59d32ea014d21e29376652096e2fc8f669
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
94836
x-matched-path
/_next/static/chunks/2309-c457ee4517200742.js
etag
W/"6727553567f11c4166a314031116c317"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::nw57n-1663795135376-65572dd7498e
content-disposition
inline; filename="2309-c457ee4517200742.js"
x-vercel-cache
HIT
%5Burl%5D-43cfcfe46920bb08.js
www.cancernetwork.com/_next/static/chunks/pages/view/
11 KB
5 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/chunks/pages/view/%5Burl%5D-43cfcfe46920bb08.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
06223f06cd0ba37084e1fd7cea7b987771b95e4b45733b400e7f9aede5189076
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
94836
x-matched-path
/_next/static/chunks/pages/view/%5Burl%5D-43cfcfe46920bb08.js
etag
W/"53fdfae43a252a58646498a60f96f7d6"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::8xcwd-1663795135376-c8ff0fa95717
content-disposition
inline; filename="[url]-43cfcfe46920bb08.js"
x-vercel-cache
HIT
_buildManifest.js
www.cancernetwork.com/_next/static/gcKZDtwiftsa2touFwUU5/
19 KB
5 KB
Script
General
Full URL
https://www.cancernetwork.com/_next/static/gcKZDtwiftsa2touFwUU5/_buildManifest.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
9ff1a2c61f11af0dea73a96fe17c1710b263a1aa98ad545edf1fed8893f304a4
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
72347
x-matched-path
/_next/static/gcKZDtwiftsa2touFwUU5/_buildManifest.js
etag
W/"a9b82779d8c288b48d64ebaa8ce7b39e"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::9ncvs-1663795135380-c73f04bc2b08
content-disposition
inline; filename="_buildManifest.js"
x-vercel-cache
HIT
_ssgManifest.js
www.cancernetwork.com/_next/static/gcKZDtwiftsa2touFwUU5/
77 B
280 B
Script
General
Full URL
https://www.cancernetwork.com/_next/static/gcKZDtwiftsa2touFwUU5/_ssgManifest.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
6f5b4aa00d2f8d6aed9935b471806bf7acef464d0c1d390260e5fe27f800c67e
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
server
Vercel
age
76302
x-matched-path
/_next/static/gcKZDtwiftsa2touFwUU5/_ssgManifest.js
etag
"b6652df95db52feb4daf4eca35380933"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::trlpb-1663795135376-200375cb950e
content-disposition
inline; filename="_ssgManifest.js"
accept-ranges
bytes
x-vercel-cache
HIT
content-length
77
_middlewareManifest.js
www.cancernetwork.com/_next/static/gcKZDtwiftsa2touFwUU5/
92 B
281 B
Script
General
Full URL
https://www.cancernetwork.com/_next/static/gcKZDtwiftsa2touFwUU5/_middlewareManifest.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
de5341313a4dc5d982ca50ae4a491e84bc5e80b0f439d87f05fc3973c1b7e59a
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
server
Vercel
age
90296
x-matched-path
/_next/static/gcKZDtwiftsa2touFwUU5/_middlewareManifest.js
etag
"7c3f7e060745668041278118c0bb3d6d"
strict-transport-security
max-age=63072000
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public,max-age=31536000,immutable
x-vercel-id
fra1:fra1::qq6vl-1663795135378-9c0c023cd0b3
content-disposition
inline; filename="_middlewareManifest.js"
accept-ranges
bytes
x-vercel-cache
HIT
content-length
92
magazine.css
www.cancernetwork.com/
37 KB
9 KB
Stylesheet
General
Full URL
https://www.cancernetwork.com/magazine.css
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
f6ea35e915c36564137473239a6de521526385c3096c2cfa3c9a3bfac343a1c1
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
71204
x-matched-path
/magazine.css
etag
W/"332261a1c862347bc46a9873dc454f5e"
strict-transport-security
max-age=63072000
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
s-maxage=300, stale-while-revalidate=60
x-vercel-id
fra1:fra1::2r9pj-1663795135158-f858c688d95e
content-disposition
inline; filename="magazine.css"
x-vercel-cache
HIT
cancernetwork-primary-10-15.png
www.cancernetwork.com/
11 KB
11 KB
Image
General
Full URL
https://www.cancernetwork.com/cancernetwork-primary-10-15.png
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
498dc2c813769b287a426368520eedb183e368fd6cb852f45ea24968a1f773b5
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
server
Vercel
age
74958
x-matched-path
/cancernetwork-primary-10-15.png
etag
"de7b9e98d63af0313f9cb863a8793d15"
strict-transport-security
max-age=63072000
content-type
image/png
access-control-allow-origin
*
cache-control
s-maxage=300, stale-while-revalidate=60
x-vercel-id
fra1:fra1::flqsz-1663795135376-997bdafdf1f7
content-disposition
inline; filename="cancernetwork-primary-10-15.png"
accept-ranges
bytes
x-vercel-cache
HIT
content-length
10883
cancernetwork_inverted_logo.png
www.cancernetwork.com/
16 KB
16 KB
Image
General
Full URL
https://www.cancernetwork.com/cancernetwork_inverted_logo.png
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
a675d717cc543f1736920ce540e27ef6aaabe6edf9353d1e49daed1d795f06ef
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
server
Vercel
age
94836
x-matched-path
/cancernetwork_inverted_logo.png
etag
"68355b20ee6d4936e75fb0f088619860"
strict-transport-security
max-age=63072000
content-type
image/png
access-control-allow-origin
*
cache-control
s-maxage=300, stale-while-revalidate=60
x-vercel-id
fra1:fra1::v8bxf-1663795135376-9920019079f2
content-disposition
inline; filename="cancernetwork_inverted_logo.png"
accept-ranges
bytes
x-vercel-cache
HIT
content-length
16246
an_mjhls_brand_logo.png
mjh-web.s3.amazonaws.com/_media/
18 KB
19 KB
Image
General
Full URL
https://mjh-web.s3.amazonaws.com/_media/an_mjhls_brand_logo.png
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.80.240 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1-w.amazonaws.com
Software
AmazonS3 /
Resource Hash
dd897c508ba0c0d9af3a7c28d41a1c1d6f286a3a4935c6acaf49218cf8bb2b01

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

Date
Wed, 21 Sep 2022 21:18:56 GMT
Last-Modified
Fri, 05 Jun 2020 15:07:22 GMT
Server
AmazonS3
x-amz-request-id
M8P97G0MDD5PSW5H
ETag
"d7be1e839cd8f620ee1ceda367eec31f"
Content-Type
image/png
x-amz-version-id
6ih9ZD5S5hErSkSYWTpE3XTOUf7pfW0i
Accept-Ranges
bytes
Content-Length
18584
x-amz-id-2
HgQ4eslBHwX4QYmmsYLVNcpMHMzlW0aL5ZMhf7YKKktBzM4rXCok7Tfx9IU5UIW2+jQrDKoSOvM=
mjhls_brand.png
www.cancernetwork.com/
6 KB
6 KB
Image
General
Full URL
https://www.cancernetwork.com/mjhls_brand.png
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
9a422058735af0ef6190cb555b6117d889697ec56c776b795225de10139e12f9
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
server
Vercel
age
84333
x-matched-path
/mjhls_brand.png
etag
"c17313cafac3da4ce6742ca146c4788e"
strict-transport-security
max-age=63072000
content-type
image/png
access-control-allow-origin
*
cache-control
s-maxage=300, stale-while-revalidate=60
x-vercel-id
fra1:fra1::kg9mt-1663795135376-2f6c323b0543
content-disposition
inline; filename="mjhls_brand.png"
accept-ranges
bytes
x-vercel-cache
HIT
content-length
5870
4fc6a3840267a7bf5439d3ce02d22355906a88e7-1200x678.jpg
cdn.sanity.io/images/0vv8moc6/cancernetwork/
4 KB
5 KB
Image
General
Full URL
https://cdn.sanity.io/images/0vv8moc6/cancernetwork/4fc6a3840267a7bf5439d3ce02d22355906a88e7-1200x678.jpg?w=250&fit=crop&auto=format
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.190.70.79 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
79.70.190.35.bc.googleusercontent.com
Software
/
Resource Hash
0537b568ba2b8f91354e1e39dbd2b1c41ef72fdcff56d12405f9c34f0b1d6161
Security Headers
Name Value
Content-Security-Policy script-src 'none'
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

content-security-policy
script-src 'none'
x-sanity-asset-storage
gcs-default
x-content-type-options
nosniff
xkey
project-0vv8moc6-cancernetwork
x-b3-traceid
fc446cbba38f16e89efdc32c2bfa4032
age
4608
x-varnish-age
0
x-b3-parentspanid
28845f2eaaac0536
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
4514
last-modified
Wed, 14 Sep 2022 20:59:36 GMT
date
Wed, 21 Sep 2022 20:02:07 GMT
vary
origin, accept
content-type
image/webp
via
1.1 google
cache-control
public, max-age=31536000, s-maxage=2592000
x-b3-spanid
57ac92f011981ef3
x-b3-sampled
0
accept-ranges
bytes
0df0c776b76232a27c69b79f7caa994d72ec9f5f-1200x800.jpg
cdn.sanity.io/images/0vv8moc6/cancernetwork/
5 KB
6 KB
Image
General
Full URL
https://cdn.sanity.io/images/0vv8moc6/cancernetwork/0df0c776b76232a27c69b79f7caa994d72ec9f5f-1200x800.jpg?w=250&fit=crop&auto=format
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.190.70.79 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
79.70.190.35.bc.googleusercontent.com
Software
/
Resource Hash
a9bac6d9739317499e2b097eb6a92140533aed862ca76e90e264a148a0aa5b51
Security Headers
Name Value
Content-Security-Policy script-src 'none'
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

content-security-policy
script-src 'none'
x-sanity-asset-storage
gcs-default
x-content-type-options
nosniff
xkey
project-0vv8moc6-cancernetwork
x-b3-traceid
a01d03dc99a79b63cc514e35413ac5f2
age
138553
x-varnish-age
12784
x-b3-parentspanid
53422b3fe4a41f06
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
5546
last-modified
Wed, 14 Sep 2022 19:03:54 GMT
date
Tue, 20 Sep 2022 06:49:42 GMT
vary
origin, accept
content-type
image/webp
via
1.1 google
cache-control
public, max-age=31536000, s-maxage=2592000
x-b3-spanid
a4a03132b30a6067
x-b3-sampled
0
accept-ranges
bytes
de022151e2f235d836457242a57a5255ea8fae1f-1200x675.jpg
cdn.sanity.io/images/0vv8moc6/cancernetwork/
3 KB
4 KB
Image
General
Full URL
https://cdn.sanity.io/images/0vv8moc6/cancernetwork/de022151e2f235d836457242a57a5255ea8fae1f-1200x675.jpg?w=250&fit=crop&auto=format
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.190.70.79 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
79.70.190.35.bc.googleusercontent.com
Software
/
Resource Hash
0cb973a20baeddd8a31369c9e5e38d06a90e76e1fe891ba003680ab99f160059
Security Headers
Name Value
Content-Security-Policy script-src 'none'
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

content-security-policy
script-src 'none'
x-sanity-asset-storage
gcs-default
x-content-type-options
nosniff
xkey
project-0vv8moc6-cancernetwork
x-b3-traceid
6a66786b3f2cdcc2401fa3afb1e05a82
age
434351
x-varnish-age
1255
x-b3-parentspanid
a5c01910394f5410
vha6-origin
image-varnish-ssd-1
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
3334
last-modified
Thu, 15 Sep 2022 13:19:56 GMT
date
Fri, 16 Sep 2022 20:39:44 GMT
vary
origin, accept
content-type
image/webp
via
1.1 google
cache-control
public, max-age=31536000, s-maxage=2592000
x-b3-spanid
1edacd40b1d7a690
x-b3-sampled
0
accept-ranges
bytes
f99812fa-7770-4a60-a74a-3df850347caf
https://www.cancernetwork.com/
390 B
0
Other
General
Full URL
blob:https://www.cancernetwork.com/f99812fa-7770-4a60-a74a-3df850347caf
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
a1f04990cdf9746528e6a613ae69fb5f3bc54c3677b6a3865af0c873d880b4fe

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

Content-Length
390
Content-Type
text/javascript
gtm.js
www.googletagmanager.com/
164 KB
60 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-5HS2GHR
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:831::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
ae9cf477a2efc30bfbb6ecacefa952a7e97808d14bd41bed0d28834c660bba47
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
vary
Accept-Encoding
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
61178
x-xss-protection
0
last-modified
Wed, 21 Sep 2022 21:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Wed, 21 Sep 2022 21:18:55 GMT
analytics.min.js
cdn.segment.com/analytics.js/v1/BBbKMoOjmhsxPnbd2nO6osz3zq67DzuN/
96 KB
26 KB
Script
General
Full URL
https://cdn.segment.com/analytics.js/v1/BBbKMoOjmhsxPnbd2nO6osz3zq67DzuN/analytics.min.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.115.169 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-115-169.fra56.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
8ff3bca5ba5be1071435d11107289b38b1129f5c6a4b62626cbc7981caa93c34

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

x-amz-version-id
u_rUZy.WS0QTyiEufs48gBoKRHroRjXh
content-encoding
br
etag
W/"eb51a6fdcbc3496d9bf2e496d7dfab7d"
age
23
x-cache
Hit from cloudfront
access-control-max-age
3000
x-amz-replication-status
COMPLETED
access-control-allow-origin
*
last-modified
Wed, 31 Aug 2022 21:05:51 GMT
server
AmazonS3
date
Wed, 21 Sep 2022 21:18:55 GMT
vary
Accept-Encoding
access-control-allow-methods
GET, HEAD
content-type
text/javascript; charset=utf-8
via
1.1 b6be6ee8d445cfa291adcacd75a3fb12.cloudfront.net (CloudFront)
cache-control
public, max-age=120
x-amz-cf-pop
FRA56-P5
x-amz-cf-id
eXRHLX6vj3BeWU3N4535o2EU3zH21CzxyEaVpKRSBeQHePq8mUEnJw==
css
fonts.googleapis.com/
19 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:100,300,400,500,500i,700,700i,900,900i&display=swap
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/_next/static/css/5384257999458475.css
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
fd3ca9b2d7793da992829ae484e4b1beb2c3cdf18dcaf7b53dac398f90782e2b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Wed, 21 Sep 2022 21:18:55 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
date
Wed, 21 Sep 2022 21:18:55 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Wed, 21 Sep 2022 21:18:55 GMT
lightbox.js
www.lightboxcdn.com/vendor/4d4adbd3-abd9-4e19-bb09-8a53b85c054a/
399 B
357 B
Script
General
Full URL
https://www.lightboxcdn.com/vendor/4d4adbd3-abd9-4e19-bb09-8a53b85c054a/lightbox.js?cb=1663795135344
Requested by
Host: www.lightboxcdn.com
URL: https://www.lightboxcdn.com/static/lightbox_mjh.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2606:4700::6810:50a5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare / ASP.NET
Resource Hash
e69b5114ae9adbf219fc9d8570c201f96b705916f9697f266ed98a751383ced9

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Wed, 21 Sep 2022 21:18:23 GMT
server
cloudflare
age
32
x-powered-by
ASP.NET
vary
Accept-Encoding
content-type
application/javascript
cf-ray
74e5d60c0bfe0229-ZRH
magazine.css
www.cancernetwork.com/
37 KB
9 KB
Other
General
Full URL
https://www.cancernetwork.com/magazine.css
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , CHACHA20_POLY1305
Server
76.76.21.123 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Vercel /
Resource Hash
f6ea35e915c36564137473239a6de521526385c3096c2cfa3c9a3bfac343a1c1
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
server
Vercel
age
94836
x-matched-path
/magazine.css
etag
W/"332261a1c862347bc46a9873dc454f5e"
strict-transport-security
max-age=63072000
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
s-maxage=300, stale-while-revalidate=60
x-vercel-id
fra1:fra1::qcqz2-1663795135377-54d11a9ddf08
content-disposition
inline; filename="magazine.css"
x-vercel-cache
HIT
user.js
www.lightboxcdn.com/vendor/4d4adbd3-abd9-4e19-bb09-8a53b85c054a/
676 KB
144 KB
Script
General
Full URL
https://www.lightboxcdn.com/vendor/4d4adbd3-abd9-4e19-bb09-8a53b85c054a/user.js?cb=637987700069541974
Requested by
Host: www.lightboxcdn.com
URL: https://www.lightboxcdn.com/vendor/4d4adbd3-abd9-4e19-bb09-8a53b85c054a/lightbox.js?cb=1663795135344
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2606:4700::6810:50a5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
ae4279f86fc1e616f6c238f6132acb6b5721fb3913d4b772da7434475606e590

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
cf-cache-status
HIT
content-md5
LVo0KW0V3WVSlIvAVYJhAw==
age
14014
cf-polished
origSize=1146871
last-modified
Wed, 14 Sep 2022 16:33:27 GMT
x-ms-lease-status
unlocked
cf-bgj
minify
server
cloudflare
vary
Accept-Encoding
content-type
application/javascript
x-ms-request-id
918c0d41-c01e-0014-455a-c8db54000000
cache-control
public, max-age=31536000
x-ms-version
2009-09-19
cf-ray
74e5d60c4c5c0229-ZRH
expires
Thu, 21 Sep 2023 21:18:55 GMT
hotjar-2139334.js
static.hotjar.com/c/
5 KB
3 KB
Script
General
Full URL
https://static.hotjar.com/c/hotjar-2139334.js?sv=7
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5HS2GHR
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.97.37 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-97-37.fra56.r.cloudfront.net
Software
/
Resource Hash
01cd865d937d42f4dc43c8a56ca98e550fde1ab58c1ab3af42f382c15b7c5c21
Security Headers
Name Value
Strict-Transport-Security max-age=604800; includeSubDomains
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:23 GMT
content-encoding
br
x-content-type-options
nosniff
age
32
x-cache
Hit from cloudfront
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=604800; includeSubDomains
access-control-allow-origin
*
x-cache-hit
1
etag
W/92ce1b8ddbb0fb653fadbe14f76595ea
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
via
1.1 03ffca0f67e3596b9a0c92342fe91598.cloudfront.net (CloudFront)
cache-control
max-age=60
x-amz-cf-pop
FRA56-P2
x-amz-cf-id
Y8o_f_CZRlVe5KzsH26q0XdCX0DZZ1cyQNIT6KHOiEkDN56fjAaK3g==
/
a5122525b8ca47d59e1e515e20e1c65a.js.ubembed.com/
497 B
720 B
Script
General
Full URL
https://a5122525b8ca47d59e1e515e20e1c65a.js.ubembed.com/
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5HS2GHR
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.129.131 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
1338e5f665c71991f20670be7ff77fdfe17c6f376391023f2803a7ba7284d373

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
x-backend-region
eu_west_1
age
1199
etag
W/43a06de8a1532b4e2b84ca06bcdad8d1-v0.179.2
vary
Accept-Encoding, Referer
x-cache
Miss from cloudfront, HIT
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=0, must-revalidate
x-amz-cf-pop
FRA2-C2
accept-ranges
none
x-amz-apigw-id
Y1AqqG4qDoEF4Iw=
pub.js
pub.doubleverify.com/signals/
67 KB
18 KB
Script
General
Full URL
https://pub.doubleverify.com/signals/pub.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5HS2GHR
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:a6e0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
45169abf0c7bb67cf7708983ec00a7c62c8beddb556112ec1ae79de86c8c9681
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self'
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Frame-Options SAMEORIGIN

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
cf-ray
74e5d60cc84a0221-ZRH
server-timing
total;dur=0
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
server
cloudflare
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
strict-transport-security
max-age=31536000; includeSubDomains
content-type
text/javascript
access-control-allow-origin
*
access-control-expose-headers
Server-Timing, Cf-Ray
cache-control
private, max-age=14400, stale-while-revalidate=345600, stale-if-error=345600
access-control-allow-credentials
true
content-security-policy
frame-ancestors 'self'
timing-allow-origin
*
fbevents.js
connect.facebook.net/en_US/
101 KB
27 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: ins1.caboodleai.net
URL: https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
844bfb2ff3311ad9b5611b51d8c72e0c483a8ceafe7c625a5c321637f9277399
Security Headers
Name Value
Content-Security-Policy default-src * data: blob: 'self';script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.google.com 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';block-all-mixed-content;upgrade-insecure-requests;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

content-security-policy
default-src * data: blob: 'self';script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.google.com 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';block-all-mixed-content;upgrade-insecure-requests;
content-encoding
gzip
x-content-type-options
nosniff
document-policy
force-load-at-top
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400,h3-29=":443"; ma=86400
content-length
26839
x-xss-protection
0
pragma
public
x-fb-debug
pVIxKCyCkgF+BpQfFcGfHSSHvMhOZ5TnUxPkVX8fv8CsQW3XlS3QJMSkq5ujnfcYQdI9bGyH8bSkgnfABiYggA==
x-fb-trip-id
2050670934
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
DENY
date
Wed, 21 Sep 2022 21:18:55 GMT
strict-transport-security
max-age=31536000; preload; includeSubDomains
content-type
application/x-javascript; charset=utf-8
vary
Accept-Encoding
cache-control
public, max-age=1200
x-fb-rlafr
0
priority
u=3,i
expires
Sat, 01 Jan 2000 00:00:00 GMT
roundtrip.js
s.adroll.com/j/2UKVTUKDWZHOZHUORA7U2Z/
64 KB
20 KB
Script
General
Full URL
https://s.adroll.com/j/2UKVTUKDWZHOZHUORA7U2Z/roundtrip.js
Requested by
Host: ins1.caboodleai.net
URL: https://ins1.caboodleai.net/en/article/165823/neoadjuvant-pegylated-lipsomal-doxorubicin
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:225e:9e00:6:9280:1080:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
b6eab2f0644e546b3e9172c755f42aca51e84425079096195ad0b8d35c7599fb

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

X-Amz-Version-Id
G8SlL0L8p_LAmF5Zu1Hrf2sTRHet9mtU
Content-Encoding
gzip
Etag
W/"eb1e4eb62a4815415ba957b48114b79e"
Age
2445
X-Amz-Server-Side-Encryption
AES256
Transfer-Encoding
chunked
X-Cache
Hit from cloudfront
Connection
keep-alive
Vary
Accept-Encoding
Via
1.1 70d755f7200c02162c7545e4ce74649a.cloudfront.net (CloudFront)
Last-Modified
Mon, 19 Sep 2022 04:52:16 GMT
Server
AmazonS3
Date
Wed, 21 Sep 2022 20:38:11 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
text/javascript; charset=utf-8
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600, must-revalidate
Access-Control-Allow-Credentials
false
X-Amz-Cf-Pop
FRA60-P4
Access-Control-Allow-Headers
*
X-Amz-Cf-Id
cAMzS-R82Bh4Vonjw-V2xZ86Qm_VThC6hFSLi8TEKTTvP-3hQ2rHgA==
KFOlCnqEu92Fr1MmEU9fBBc4.woff2
fonts.gstatic.com/s/roboto/v30/
16 KB
16 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmEU9fBBc4.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:100,300,400,500,500i,700,700i,900,900i&display=swap
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:809::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b019538234514166ec7665359d097403358f8a4c991901983922fb4d56989f1e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.cancernetwork.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 20:10:25 GMT
x-content-type-options
nosniff
age
4110
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15920
x-xss-protection
0
last-modified
Wed, 11 May 2022 19:24:45 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Thu, 21 Sep 2023 20:10:25 GMT
KFOlCnqEu92Fr1MmWUlfBBc4.woff2
fonts.gstatic.com/s/roboto/v30/
15 KB
16 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmWUlfBBc4.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:100,300,400,500,500i,700,700i,900,900i&display=swap
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:809::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f5aebdfea35d1e7656ef4acc5db1f243209755ae3300943ef8fc6280f363c860
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.cancernetwork.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Sun, 18 Sep 2022 05:29:41 GMT
x-content-type-options
nosniff
age
316154
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15860
x-xss-protection
0
last-modified
Wed, 11 May 2022 19:24:42 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Mon, 18 Sep 2023 05:29:41 GMT
KFOmCnqEu92Fr1Mu4mxK.woff2
fonts.gstatic.com/s/roboto/v30/
15 KB
15 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v30/KFOmCnqEu92Fr1Mu4mxK.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:100,300,400,500,500i,700,700i,900,900i&display=swap
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:809::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f6734f8177112c0839b961f96d813fcb189d81b60e96c33278c1983b6f419615
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.cancernetwork.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Thu, 15 Sep 2022 08:01:51 GMT
x-content-type-options
nosniff
age
566224
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15744
x-xss-protection
0
last-modified
Wed, 11 May 2022 19:24:48 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 15 Sep 2023 08:01:51 GMT
settings
cdn.segment.com/v1/projects/BBbKMoOjmhsxPnbd2nO6osz3zq67DzuN/
1 KB
1 KB
XHR
General
Full URL
https://cdn.segment.com/v1/projects/BBbKMoOjmhsxPnbd2nO6osz3zq67DzuN/settings
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/BBbKMoOjmhsxPnbd2nO6osz3zq67DzuN/analytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.115.169 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-115-169.fra56.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
202d798492f754ba5c144a165aa9600d24bf5df0043fa006330f27d51f982097

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

x-amz-version-id
JD_lm3zLIYd8G9El40OAa3B0kPhQuqFL
content-encoding
gzip
etag
W/"6b005cbe91bb129b67b5d245417909a0"
age
3356
x-cache
Hit from cloudfront
access-control-max-age
3000
x-amz-replication-status
COMPLETED
access-control-allow-origin
*
last-modified
Thu, 14 Jul 2022 13:11:34 GMT
server
AmazonS3
date
Wed, 21 Sep 2022 20:23:03 GMT
vary
Accept-Encoding
access-control-allow-methods
GET, HEAD
content-type
application/json; charset=utf-8
via
1.1 342054511f9732c450e11bade76323dc.cloudfront.net (CloudFront)
cache-control
public, max-age=10800
x-amz-cf-pop
FRA56-P5
x-amz-cf-id
Mf58Tt7xy8QvTKiD646KA0h6sz6q04g_Y2R6LlrrEOAT24QuJKFbFg==
870.bundle.323974846b6d45afb45e.js
cdn.segment.com/analytics-next/bundles/
17 KB
5 KB
Script
General
Full URL
https://cdn.segment.com/analytics-next/bundles/870.bundle.323974846b6d45afb45e.js
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/BBbKMoOjmhsxPnbd2nO6osz3zq67DzuN/analytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.115.169 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-115-169.fra56.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
85fa85cbca5efaa81351f2e9b1e8e53916644bff91da6ffc762a151247501ebc

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Sat, 27 Aug 2022 01:38:35 GMT
content-encoding
br
vary
Accept-Encoding
age
2230821
x-cache
Hit from cloudfront
x-amz-replication-status
COMPLETED
access-control-allow-origin
*
last-modified
Fri, 26 Aug 2022 03:04:21 GMT
server
AmazonS3
etag
W/"d471f2a8b801a51bbc09c91b3f90b749"
access-control-max-age
3000
access-control-allow-methods
GET, HEAD
x-amz-version-id
qltndKW7QqDrf8ZSZrei2HuGEvEC2x.O
via
1.1 b6be6ee8d445cfa291adcacd75a3fb12.cloudfront.net (CloudFront)
cache-control
public,max-age=31536000,immutable
x-amz-cf-pop
FRA56-P5
content-type
application/javascript
x-amz-cf-id
sUirLWE-ZoT-55WKlMHUMJukXUp9Aw5FWNF5D1OLjrw14f9918DHWQ==
ajs-destination.bundle.35a8f6f19959bf2f455f.js
cdn.segment.com/analytics-next/bundles/
10 KB
4 KB
Script
General
Full URL
https://cdn.segment.com/analytics-next/bundles/ajs-destination.bundle.35a8f6f19959bf2f455f.js
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/BBbKMoOjmhsxPnbd2nO6osz3zq67DzuN/analytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.115.169 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-115-169.fra56.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
9abdea148f6bb2fd5f4d3a947661b46f077584cfc3691deb29fa7cb25d2e00a6

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Thu, 01 Sep 2022 06:12:31 GMT
content-encoding
br
vary
Accept-Encoding
age
1782384
x-cache
Hit from cloudfront
x-amz-replication-status
COMPLETED
access-control-allow-origin
*
last-modified
Tue, 30 Aug 2022 21:47:48 GMT
server
AmazonS3
etag
W/"e0f89f667fb8d2b50aa8e29a86a4c9b1"
access-control-max-age
3000
access-control-allow-methods
GET, HEAD
x-amz-version-id
1ps0Y.cQfeUJnD6vrqu.rtfMUGfr8v9x
via
1.1 b6be6ee8d445cfa291adcacd75a3fb12.cloudfront.net (CloudFront)
cache-control
public,max-age=31536000,immutable
x-amz-cf-pop
FRA56-P5
content-type
application/javascript
x-amz-cf-id
bRdGrBE_QRqySs1V6qFMCnQkifWUeg56nOSyaN98_YYICQZ2a06ZuA==
fb_lightbox.2.1.5.css
www.lightboxcdn.com/static/
4 KB
1 KB
Stylesheet
General
Full URL
https://www.lightboxcdn.com/static/fb_lightbox.2.1.5.css?cb=637987700069541974
Requested by
Host: www.lightboxcdn.com
URL: https://www.lightboxcdn.com/vendor/4d4adbd3-abd9-4e19-bb09-8a53b85c054a/user.js?cb=637987700069541974
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2606:4700::6810:50a5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
0b9028c7ecccf4f31fafcfca176cd6ed38197d7b3d6ea4c107b98af8eecc525b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
br
cf-cache-status
HIT
content-md5
q4B4xYJoZwx9ikt94o1nCA==
age
14014
cf-polished
origSize=6016
x-ms-meta-cbmodifiedtime
Wed, 10 Apr 2019 18:50:43 GMT
last-modified
Wed, 10 Apr 2019 19:06:17 GMT
x-ms-lease-status
unlocked
cf-bgj
minify
server
cloudflare
vary
Accept-Encoding
content-type
text/css
x-ms-request-id
e88c1b1c-a01e-002d-355a-c89bf0000000
cache-control
public, max-age=31536000
x-ms-version
2009-09-19
cf-ray
74e5d60e380d0229-ZRH
expires
Thu, 21 Sep 2023 21:18:55 GMT
z
lightboxapi.azurewebsites.net/z9gd/43297/www.cancernetwork.com/jsonp/
542 B
798 B
Script
General
Full URL
https://lightboxapi.azurewebsites.net/z9gd/43297/www.cancernetwork.com/jsonp/z?cb=1663795135713&callback=jQuery171043735176183430857_1663795135688&_=1663795135715
Requested by
Host: www.lightboxcdn.com
URL: https://www.lightboxcdn.com/vendor/4d4adbd3-abd9-4e19-bb09-8a53b85c054a/user.js?cb=637987700069541974
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
20.40.202.0 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
3f426106a46b512bbc0f3acde5fe83bd20296b70727d160c5773a1bc8b77b7e0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

Date
Wed, 21 Sep 2022 21:18:55 GMT
Content-Encoding
gzip
Transfer-Encoding
chunked
Server
Microsoft-IIS/10.0
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript
t.gif
www.lightboxcdn.com/z9g/
35 B
258 B
Image
General
Full URL
https://www.lightboxcdn.com/z9g/t.gif?c=1663795135700&h=www.cancernetwork.com&e=p&u=43297
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2606:4700::6810:50a5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Wed, 21 Sep 2022 21:18:55 GMT
cf-cache-status
HIT
content-md5
KNaBTzCeoon4R8ac+RGUxg==
age
1284039
cf-polished
status=not_needed
x-ms-meta-cbmodifiedtime
Tue, 26 Feb 2019 00:59:40 GMT
content-length
35
x-ms-lease-status
unlocked
last-modified
Tue, 26 Feb 2019 01:15:02 GMT
server
cloudflare
etag
0x8D69B87D5A1B25F
vary
Accept-Encoding
content-type
image/gif
x-ms-request-id
349b9e43-e01e-0063-4e83-b113e4000000
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
74e5d60e58220229-ZRH
cf-bgj
imgq:85,h2pri
analytics.js
www.google-analytics.com/
49 KB
19 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/_next/static/chunks/pages/_app-629c8d5068702e80.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
9e25469f734732205f33dd80ff8ca12080406c18d2fa99a1f368103e51f7999f
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Sun, 11 Sep 2022 13:50:09 GMT
server
Golfe2
age
1015
date
Wed, 21 Sep 2022 21:02:00 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
19826
expires
Wed, 21 Sep 2022 23:02:00 GMT
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/
167 KB
57 KB
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/_next/static/chunks/3600-0ed0468a1b9f30d5.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:830::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f921ee583b32b0ffdbcf93a679f5983792f6c15af1fb9d756ec1047fac02ee04
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
58009
x-xss-protection
0
server
cafe
etag
2257953686958143315
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600
timing-allow-origin
*
expires
Wed, 21 Sep 2022 21:18:55 GMT
generic
match.adsrvr.org/track/cmf/
Redirect Chain
  • https://trc.lhmos.com/uid/set?mjhPubId=&mcode=28436&mid=582
  • https://secure.adnxs.com/getuidu?https://trc.lhmos.com/uid/save/?uid=$UID&mjhPubId=&mcode=28436&mid=582
  • https://secure.adnxs.com/bounce?%2Fgetuidu%3Fhttps%3A%2F%2Ftrc.lhmos.com%2Fuid%2Fsave%2F%3Fuid%3D%24UID%26mjhPubId%3D%26mcode%3D28436%26mid%3D582
  • https://trc.lhmos.com/uid/save/?uid=853839932400296011&mjhPubId=&mcode=28436&mid=582
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=v0gsn3b&ttd_tpi=1&ttd_puid=582&ttd_puid=null&ttd_puid=853839932400296011&ttd_puid=&ttd_puid=ec6fd4e3-ce97-4f29-b582-67026bc49faf
70 B
264 B
Script
General
Full URL
https://match.adsrvr.org/track/cmf/generic?ttd_pid=v0gsn3b&ttd_tpi=1&ttd_puid=582&ttd_puid=null&ttd_puid=853839932400296011&ttd_puid=&ttd_puid=ec6fd4e3-ce97-4f29-b582-67026bc49faf
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Server
15.197.193.217 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
a12b7a488abeaa9e4.awsglobalaccelerator.com
Software
/
Resource Hash
d9e59641a8f690d854acb9ef992583e66381ce366a15c647043024a105852f96

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:56 GMT
cache-control
private,no-cache, must-revalidate
x-aspnet-version
4.0.30319
content-type
image/gif
content-length
70
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"

Redirect headers

date
Wed, 21 Sep 2022 21:18:56 GMT
via
1.1 google
x-content-type-options
nosniff
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
1; mode=block
pragma
no-cache
location
https://match.adsrvr.org/track/cmf/generic?ttd_pid=v0gsn3b&ttd_tpi=1&ttd_puid=582&ttd_puid=null&ttd_puid=853839932400296011&ttd_puid=&ttd_puid=ec6fd4e3-ce97-4f29-b582-67026bc49faf
x-frame-options
DENY
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-language
de-DE
access-control-allow-origin
*
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
access-control-allow-headers
x-requested-with
expires
0
/
trc.lhmos.com/msmnt/save/
Redirect Chain
  • https://trc.lhmos.com/msmnt/?id=32860&cid=e896b993-9f71-44ac-962a-72b3eb82ed3d
  • https://secure.adnxs.com/getuidu?https://trc.lhmos.com/msmnt/save/?uid=$UID&id=32860&cid=e896b993-9f71-44ac-962a-72b3eb82ed3d
  • https://secure.adnxs.com/bounce?%2Fgetuidu%3Fhttps%3A%2F%2Ftrc.lhmos.com%2Fmsmnt%2Fsave%2F%3Fuid%3D%24UID%26id%3D32860%26cid%3De896b993-9f71-44ac-962a-72b3eb82ed3d
  • https://trc.lhmos.com/msmnt/save/?uid=853839932400296011&id=32860&cid=e896b993-9f71-44ac-962a-72b3eb82ed3d
1 KB
1 KB
Script
General
Full URL
https://trc.lhmos.com/msmnt/save/?uid=853839932400296011&id=32860&cid=e896b993-9f71-44ac-962a-72b3eb82ed3d
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H3
Server
34.102.246.198 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
198.246.102.34.bc.googleusercontent.com
Software
/
Resource Hash
d5b6112d3ed969d3f4f3934a8bb08ef868f7b87b81cd0f21786250d37b84a67a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:56 GMT
via
1.1 google
x-content-type-options
nosniff
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1161
x-xss-protection
1; mode=block
pragma
no-cache
x-frame-options
DENY
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-type
application/javascript
access-control-allow-origin
*
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
access-control-allow-headers
x-requested-with
expires
0

Redirect headers

Pragma
no-cache
Date
Wed, 21 Sep 2022 21:18:56 GMT
X-Proxy-Origin
193.27.14.41; 193.27.14.41; 950.bm-nginx-loadbalancer.mgmt.ams3.adnexus.net; adnxs.com
AN-X-Request-Uuid
548c70e5-611d-467c-b952-efecf83cbb11
Server
nginx/1.21.3
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://trc.lhmos.com/msmnt/save/?uid=853839932400296011&id=32860&cid=e896b993-9f71-44ac-962a-72b3eb82ed3d
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
gpt.js
securepubads.g.doubleclick.net/tag/js/
80 KB
28 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/_next/static/chunks/pages/_app-629c8d5068702e80.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:827::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
fdf658733b627a9f4cd5ac14181b37f5dafbf0212402868602b80773ea8bba42
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27765
x-xss-protection
0
server
sffe
etag
"1341 / 596 of 1000 / last-modified: 1663758362"
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Wed, 21 Sep 2022 21:18:55 GMT
modules.f4179535429bf14e77ee.js
script.hotjar.com/
252 KB
64 KB
Script
General
Full URL
https://script.hotjar.com/modules.f4179535429bf14e77ee.js
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-2139334.js?sv=7
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.222.236.122 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-52-222-236-122.fra56.r.cloudfront.net
Software
/
Resource Hash
54502058e97eaac693950652b3243bf71346305b1b3c5a2fa479c27dd8d5a73f
Security Headers
Name Value
Strict-Transport-Security max-age=604800; includeSubDomains
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Tue, 20 Sep 2022 16:01:07 GMT
content-encoding
br
x-content-type-options
nosniff
age
105468
x-cache
Hit from cloudfront
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=604800; includeSubDomains
content-length
65420
access-control-allow-origin
*
last-modified
Tue, 20 Sep 2022 16:00:26 GMT
etag
"4a99ec558aff503901b33da3d9b4ec1b"
vary
Accept-Encoding
content-type
application/javascript
via
1.1 ade2b5e2170ccd4f394b741b27bb0eec.cloudfront.net (CloudFront)
cache-control
max-age=31536000
x-amz-cf-pop
FRA56-P4
accept-ranges
bytes
x-robots-tag
none
x-amz-cf-id
JflLThkKbDTmoKIm08XG53hSrK2HifJUZ7Q-yzJw6EQpmJ2zVlz1eA==
2105787799642953
connect.facebook.net/signals/config/
293 KB
84 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/2105787799642953?v=2.9.83&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
34af564a0d4ef2671f1164feb469b6c201e249cb0f78e22ab5804fd8f32ce1d3
Security Headers
Name Value
Content-Security-Policy default-src * data: blob: 'self';script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.google.com 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';block-all-mixed-content;upgrade-insecure-requests;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

content-security-policy
default-src * data: blob: 'self';script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.google.com 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';block-all-mixed-content;upgrade-insecure-requests;
content-encoding
gzip
x-content-type-options
nosniff
document-policy
force-load-at-top
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400,h3-29=":443"; ma=86400
content-length
86324
x-xss-protection
0
pragma
public
x-fb-debug
RC3/gXdhe7M5qR+PveylfXM141PnJbfx0UDTs6L7RQq+4mAuFLe27+tQyj3BBFE1c78ccXxL3mDjrIJ5hISldQ==
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
DENY
date
Wed, 21 Sep 2022 21:18:55 GMT
strict-transport-security
max-age=31536000; preload; includeSubDomains
content-type
application/x-javascript; charset=utf-8
vary
Accept-Encoding
cache-control
public, max-age=1200
x-fb-rlafr
0
priority
u=3,i
expires
Sat, 01 Jan 2000 00:00:00 GMT
bundle.js
assets.ubembed.com/universalscript/releases/v0.179.2/
174 KB
48 KB
Script
General
Full URL
https://assets.ubembed.com/universalscript/releases/v0.179.2/bundle.js
Requested by
Host: a5122525b8ca47d59e1e515e20e1c65a.js.ubembed.com
URL: https://a5122525b8ca47d59e1e515e20e1c65a.js.ubembed.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
108.138.17.27 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-108-138-17-27.fra56.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
b318b179b35ca92c87626801798f3bce3864172926ae10288f0460a53f30177c

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 25 May 2022 02:45:33 GMT
content-encoding
gzip
last-modified
Tue, 05 Apr 2022 16:31:05 GMT
server
AmazonS3
age
10348402
etag
W/"359008fe01078c59c66e034866170bd2"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
via
1.1 da749f044be44d389a30372d73356c4e.cloudfront.net (CloudFront)
cache-control
max-age=31536000
x-amz-cf-pop
FRA56-P7
x-amz-cf-id
2rWj6PtuFo1PVdvUOMFDbOnsaePgQhqOn6PJNPEOBkl3On24uvA27w==
show_ads_impl_with_ama_fy2021.js
pagead2.googlesyndication.com/pagead/managed/js/adsense/m202209080101/
346 KB
122 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202209080101/show_ads_impl_with_ama_fy2021.js?client=ca-pub-7203212329370932&plah=www.cancernetwork.com
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:830::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
37bea528a2323f0df68b7ac367c4d42f64ea46c73e9bbf05a3632cd8f4c94052
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
124742
x-xss-protection
0
server
cafe
etag
5724955518086972490
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
expires
Wed, 21 Sep 2022 21:18:55 GMT
zrt_lookup.html
googleads.g.doubleclick.net/pagead/html/r20220915/r20190131/ Frame 5DAC
10 KB
5 KB
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/html/r20220915/r20190131/zrt_lookup.html
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f7408c25067cd0a9d9fe835cb4c05e394a50751d3fcde0c461db19a309abb02a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancernetwork.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

age
35132
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
cache-control
public, max-age=1209600
content-encoding
gzip
content-length
4420
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Wed, 21 Sep 2022 11:33:23 GMT
etag
9671129459699598864
expires
Wed, 05 Oct 2022 11:33:23 GMT
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
index.js
s.adroll.com/j/exp/
Redirect Chain
  • https://s.adroll.com/j/exp/2UKVTUKDWZHOZHUORA7U2Z/index.js
  • https://s.adroll.com/j/exp/index.js
28 B
785 B
Script
General
Full URL
https://s.adroll.com/j/exp/index.js
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
HTTP/1.1
Server
2600:9000:225e:9e00:6:9280:1080:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
f59e5f34a941183aacaed25322ac0856628493c2cfd936ded3fddc0a49510e52

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

X-Amz-Version-Id
VS8aSrwndm.MeiNnyJ10ruHH56v74CIF
Via
1.1 70d755f7200c02162c7545e4ce74649a.cloudfront.net (CloudFront)
Etag
"5816cced8568d223aa09d889f300692b"
Age
67367
X-Amz-Server-Side-Encryption
AES256
X-Cache
Hit from cloudfront
Connection
keep-alive
Vary
Accept-Encoding
Content-Length
28
Last-Modified
Fri, 02 Sep 2022 17:25:28 GMT
Server
AmazonS3
Date
Wed, 21 Sep 2022 02:36:09 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
false
X-Amz-Cf-Pop
FRA60-P4
Accept-Ranges
bytes
Access-Control-Allow-Headers
*
X-Amz-Cf-Id
Njmog0rrI3_81gJGCNgQulMPum9ZBfRvK80yUQ6dVbgzfGYQEzWf_Q==

Redirect headers

Date
Wed, 21 Sep 2022 04:49:49 GMT
Via
1.1 70d755f7200c02162c7545e4ce74649a.cloudfront.net (CloudFront)
Age
59345
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
0
Server
AmazonS3
Location
https://s.adroll.com/j/exp/index.js
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
application/xml
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
false
X-Amz-Cf-Pop
FRA60-P4
Access-Control-Allow-Headers
*
X-Amz-Cf-Id
cKZEhEdaMKe9RX2WPSnBoOyTFKu5t9cYqUGlpqe8fP3bMf1QKcuifQ==
box-69edcc3187336f9b0a3fbb4c73be9fe6.html
vars.hotjar.com/ Frame E7B2
2 KB
1 KB
Document
General
Full URL
https://vars.hotjar.com/box-69edcc3187336f9b0a3fbb4c73be9fe6.html
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-2139334.js?sv=7
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.147.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-147-113.fra60.r.cloudfront.net
Software
/
Resource Hash
867b23a408fa99143955de5665345cda886857174c328d2828e5dcd33bd98cd1
Security Headers
Name Value
Strict-Transport-Security max-age=604800; includeSubDomains

Request headers

Referer
https://www.cancernetwork.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

accept-ranges
bytes
age
1252909
cache-control
max-age=31536000
content-encoding
br
content-length
1044
content-type
text/html
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Wed, 07 Sep 2022 09:17:07 GMT
etag
"f6a9ca04b0687ea3c0d98e8430c8c77b"
last-modified
Wed, 07 Sep 2022 09:16:57 GMT
strict-transport-security
max-age=604800; includeSubDomains
vary
Accept-Encoding
via
1.1 21369bf2bfeb79adaa5bef1cb96f8540.cloudfront.net (CloudFront)
x-amz-cf-id
xoaJyoO6oMkaRjXYhfhsidl9eSwLcU1qtj_-6g5GbBfqk4YHckSpFw==
x-amz-cf-pop
FRA60-P4
x-cache
Hit from cloudfront
x-robots-tag
none
/
vtrk.doubleverify.com/
0
187 B
Ping
General
Full URL
https://vtrk.doubleverify.com/?v=1&t=event&ec=page&cd105=%40dvpub%2Fsignals-pagetag%400.0.2&cid=a7863245-dc61-466d-ad77-b81b779621cd&z=679171088881&ctx=20083417&cd160=065ef7b1-0a66-4684-8b44-d1ac71f38364&cd161=https%3A%2F%2Fwww.cancernetwork.com%2Fview%2Fneoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer&ea=load-pq&cd180=network&cm180=103&cm181=0&cm182=22&cm183=34&cm184=40&cm185=4&cm186=519&cm191=0&cmp=DV464021
Requested by
Host: pub.doubleverify.com
URL: https://pub.doubleverify.com/signals/pub.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.213.31.46 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-213-31-46.eu-west-1.compute.amazonaws.com
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

access-control-allow-origin
https://www.cancernetwork.com
date
Wed, 21 Sep 2022 21:18:56 GMT
cache-control
no-cache
access-control-allow-credentials
true
server
nginx
vary
Origin
access-control-allow-methods
GET, POST, OPTIONS
schemaFilter.bundle.debb169c1abb431faaa6.js
cdn.segment.com/analytics-next/bundles/
2 KB
1 KB
Script
General
Full URL
https://cdn.segment.com/analytics-next/bundles/schemaFilter.bundle.debb169c1abb431faaa6.js
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/BBbKMoOjmhsxPnbd2nO6osz3zq67DzuN/analytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.115.169 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-115-169.fra56.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
e8771b238c60c36fc935fd2dad0aed6e70cea50a635ff4f89f394a968a258c42

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Sat, 30 Jul 2022 15:59:56 GMT
content-encoding
br
vary
Accept-Encoding
age
4598340
x-cache
Hit from cloudfront
x-amz-replication-status
COMPLETED
access-control-allow-origin
*
last-modified
Thu, 28 Jul 2022 21:17:25 GMT
server
AmazonS3
etag
W/"3e448afdfea355c0f19700d04431ce7d"
access-control-max-age
3000
access-control-allow-methods
GET, HEAD
x-amz-version-id
bdGJW00hoMEULfpND6wyp6DIUgkdrIDO
via
1.1 b6be6ee8d445cfa291adcacd75a3fb12.cloudfront.net (CloudFront)
cache-control
public,max-age=31536000,immutable
x-amz-cf-pop
FRA56-P5
content-type
application/javascript
x-amz-cf-id
P0bi_vEI-isJQJywirmCrafxezaAnb4fKsck6bb7WZQqiz-uyyuo_g==
collect
www.google-analytics.com/j/
4 B
24 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j97&a=2039374913&t=pageview&_s=1&dl=https%3A%2F%2Fwww.cancernetwork.com%2Fview%2Fneoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer&dr=https%3A%2F%2Fins1.caboodleai.net%2F&dp=%2Fview%2Fneoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer&ul=en-us&de=UTF-8&dt=Neoadjuvant%20Pegylated%20Lipsomal%20Doxorubicin%2FCyclophosphamide%20Plus%20Trastuzumab%2FPertuzumab%20Yields%20Promising%20Efficacy%20in%20HER2%2B%20Breast%20Cancer&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YEDAAAABAAAAAC~&jid=487312708&gjid=1367939433&cid=330794310.1663795136&tid=UA-630614-16&_gid=1255294185.1663795136&_r=1&_slc=1&cd8=&cd9=news%20clinical%2Fher2-positive-breast-cancer%20conference%20&cd10=https%3A%2F%2Fins1.caboodleai.net%2F&cd11=conference%2Fesmo&cd12=&cd13=&cd14=Russ%20Conroy%20&cd15=neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer&cd16=200&z=191927996
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
aec60bc104db041b1512185839f18f52986df7e569e5445f740dd60f763fbca8
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.cancernetwork.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:56 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.cancernetwork.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
www.google-analytics.com/j/
2 B
22 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j97&a=2039374913&t=pageview&_s=1&dl=https%3A%2F%2Fwww.cancernetwork.com%2Fview%2Fneoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer&dr=https%3A%2F%2Fins1.caboodleai.net%2F&dp=%2Fview%2Fneoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer&ul=en-us&de=UTF-8&dt=Neoadjuvant%20Pegylated%20Lipsomal%20Doxorubicin%2FCyclophosphamide%20Plus%20Trastuzumab%2FPertuzumab%20Yields%20Promising%20Efficacy%20in%20HER2%2B%20Breast%20Cancer&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YEDAAAABAAAAAC~&jid=1728437068&gjid=1343442191&cid=330794310.1663795136&tid=UA-155582410-3&_gid=1255294185.1663795136&_r=1&_slc=1&cd8=&cd9=news%20clinical%2Fher2-positive-breast-cancer%20conference%20&cd10=https%3A%2F%2Fins1.caboodleai.net%2F&cd11=conference%2Fesmo&cd12=&cd13=&cd14=Russ%20Conroy%20&cd15=neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer&cd16=200&z=1555620901
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
a048e640908046be06e00eab37742b5d5ff80964af58cfd22f7cb2de4dfe375f
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.cancernetwork.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:56 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.cancernetwork.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_2022091501.js
securepubads.g.doubleclick.net/gpt/
376 KB
127 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022091501.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:827::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
2838ada1a2e98ea67fbff5622ae6dbc293c5cae3f50be29febaa03b9a4bd8627
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 16:55:19 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
15817
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
130101
x-xss-protection
0
last-modified
Thu, 15 Sep 2022 08:34:40 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
public, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Thu, 21 Sep 2023 16:55:19 GMT
ppub_config
securepubads.g.doubleclick.net/pagead/
117 B
119 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/pagead/ppub_config?ippd=www.cancernetwork.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:827::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
3a023012719781cbb475aa6cd0c777a9d8112b330157a49b1068ff8b8b7e0297
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 21 Sep 2022 21:18:56 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
94
x-xss-protection
0
expires
Wed, 21 Sep 2022 21:18:56 GMT
/
www.facebook.com/tr/
44 B
409 B
Image
General
Full URL
https://www.facebook.com/tr/?id=2105787799642953&ev=PageView&dl=https%3A%2F%2Fwww.cancernetwork.com%2Fview%2Fneoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer&rl=https%3A%2F%2Fins1.caboodleai.net%2F&if=false&ts=1663795136078&sw=1600&sh=1200&v=2.9.83&r=stable&a=tmgoogletagmanager&ec=0&o=30&fbp=fb.1.1663795136077.1667531310&it=1663795135886&coo=false&rqm=GET
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:56 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
cache-control
no-cache, must-revalidate, max-age=0
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length
44
expires
Wed, 21 Sep 2022 21:18:56 GMT
collect
stats.g.doubleclick.net/j/
4 B
25 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j97&tid=UA-630614-16&cid=330794310.1663795136&jid=487312708&gjid=1367939433&_gid=1255294185.1663795136&_u=YEDAAAAAAAAAAC~&z=2120314725
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:400c:c08::9a Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
84e01419bd81f32ac6df0f75f49c604fda9172000a3ae432b3c47b2a6a712d80
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.cancernetwork.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
date
Wed, 21 Sep 2022 21:18:56 GMT
content-type
text/plain
access-control-allow-origin
https://www.cancernetwork.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
2UKVTUKDWZHOZHUORA7U2Z
d.adroll.com/consent/check/
439 B
532 B
Script
General
Full URL
https://d.adroll.com/consent/check/2UKVTUKDWZHOZHUORA7U2Z?arrfrr=https%3A%2F%2Fwww.cancernetwork.com%2Fview%2Fneoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer&_s=953f6de75d64ca2944fecffac1c2f40c&_b=2
Requested by
Host: s.adroll.com
URL: https://s.adroll.com/j/2UKVTUKDWZHOZHUORA7U2Z/roundtrip.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
63.33.188.239 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-63-33-188-239.eu-west-1.compute.amazonaws.com
Software
nginx/1.20.0 /
Resource Hash
f896586d9d325e80cd7f39d8aa4b2fc5b9b4fabf1b337271920b400977784dff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:56 GMT
server
nginx/1.20.0
content-length
439
content-type
application/javascript
p
api.segment.io/v1/
21 B
177 B
Fetch
General
Full URL
https://api.segment.io/v1/p
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/BBbKMoOjmhsxPnbd2nO6osz3zq67DzuN/analytics.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.25.176.52 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-25-176-52.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
12f71cb993958eefc4bdb41d7dbbda490779a9c7aba448f7be52bb63912e0254
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.cancernetwork.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.cancernetwork.com
date
Wed, 21 Sep 2022 21:18:56 GMT
strict-transport-security
max-age=31536000
content-length
21
vary
Origin
content-type
application/json
t
api.segment.io/v1/
21 B
178 B
Fetch
General
Full URL
https://api.segment.io/v1/t
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/BBbKMoOjmhsxPnbd2nO6osz3zq67DzuN/analytics.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.25.176.52 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-25-176-52.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
12f71cb993958eefc4bdb41d7dbbda490779a9c7aba448f7be52bb63912e0254
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.cancernetwork.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.cancernetwork.com
date
Wed, 21 Sep 2022 21:18:56 GMT
strict-transport-security
max-age=31536000
content-length
21
vary
Origin
content-type
application/json
ga-audiences
www.google.com/ads/
42 B
63 B
Image
General
Full URL
https://www.google.com/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j97&tid=UA-630614-16&cid=330794310.1663795136&jid=487312708&_u=YEDAAAAAAAAAAC~&z=1059039777
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:56 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
42 B
63 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j97&tid=UA-630614-16&cid=330794310.1663795136&jid=487312708&_u=YEDAAAAAAAAAAC~&z=1059039777
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82f::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:56 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pub.json
pub.doubleverify.com/signals/
989 B
885 B
Fetch
General
Full URL
https://pub.doubleverify.com/signals/pub.json?ctx=20083417&cmp=DV464021&signals=ids,bsc,vlp&url=https%3A%2F%2Fwww.cancernetwork.com%2Fview%2Fneoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer&adunits[4688/cmpm.cancernetwork][]=300x251,640x480&adunits[4688/cmpm.cancernetwork][]=300x50,320x50,728x90,970x90&adunits[4688/cmpm.cancernetwork][]=300x100,fluid&adunits[4688/cmpm.cancernetwork][]=200x420,200x480,200x520,200x560,200x620,200x660,200x680,200x720&adunits[4688/cmpm.cancernetwork][]=300x100,300x250,300x600&adunits[4688/cmpm.cancernetwork][]=300x100,300x250,300x50,300x600,320x50
Requested by
Host: pub.doubleverify.com
URL: https://pub.doubleverify.com/signals/pub.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:a6e0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3f9e0fa424ecf2bdb9c3bca8fa668a3ce13d4124b2ba5878bfe5307c6d415e15
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self'
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Frame-Options SAMEORIGIN

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

date
Wed, 21 Sep 2022 21:18:56 GMT
content-encoding
br
cf-ray
74e5d6120de80200-ZRH
server-timing
total;dur=26, ids;desc="ids iqc/hc";dur=23, bsc;desc="bsc iqc/hc";dur=10, vlp;desc="vlp kv";dur=26, vp.adu0;desc="vp.adu0 kv";dur=26, rauth;desc="rauth kv";dur=18
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
server
cloudflare
x-frame-options
SAMEORIGIN
vary
User-Agent, Referer, Accept-Encoding
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/json
access-control-allow-origin
https://www.cancernetwork.com
access-control-expose-headers
Server-Timing, Cf-Ray
cache-control
private, max-age=867, stale-while-revalidate=345600, stale-if-error=345600
access-control-allow-credentials
true
content-security-policy
frame-ancestors 'self'
timing-allow-origin
*
consent_tcfv2.js
s.adroll.com/j/
410 KB
55 KB
Script
General
Full URL
https://s.adroll.com/j/consent_tcfv2.js
Requested by
Host: s.adroll.com
URL: https://s.adroll.com/j/2UKVTUKDWZHOZHUORA7U2Z/roundtrip.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:225e:9e00:6:9280:1080:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
91144fbcc0e3f609b021e362ec29d2a9b58f15e840f229eb99ea2c04d927882b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

X-Amz-Version-Id
44sIT20LqRj70wQHqyIoOw7etYYdjkbK
Content-Encoding
gzip
Etag
W/"0a7d0ea8d7d31b07e925fe340acf431b"
Age
72
X-Amz-Server-Side-Encryption
AES256
Transfer-Encoding
chunked
X-Cache
Hit from cloudfront
Connection
keep-alive
Vary
Accept-Encoding
Via
1.1 70d755f7200c02162c7545e4ce74649a.cloudfront.net (CloudFront)
Last-Modified
Wed, 04 May 2022 19:41:48 GMT
Server
AmazonS3
Date
Wed, 21 Sep 2022 21:17:52 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=300, must-revalidate
Access-Control-Allow-Credentials
false
X-Amz-Cf-Pop
FRA60-P4
Access-Control-Allow-Headers
*
X-Amz-Cf-Id
dA0lKqWbyYucLL_i0C6e5xxBhQakMo0ix4CNWua4S-KZ4i7owjxhAw==
imptr
secure.adnxs.com/
43 B
841 B
Image
General
Full URL
https://secure.adnxs.com/imptr?id=64400
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.89.210.141 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),
Reverse DNS
950.bm-nginx-loadbalancer.mgmt.ams3.adnexus.net
Software
nginx/1.21.3 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

Pragma
no-cache
Date
Wed, 21 Sep 2022 21:18:56 GMT
X-Proxy-Origin
193.27.14.41; 193.27.14.41; 950.bm-nginx-loadbalancer.mgmt.ams3.adnexus.net; adnxs.com
AN-X-Request-Uuid
e6b5a6a3-f7f5-42e2-8177-96d29c91ac47
Server
nginx/1.21.3
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
generic
match.adsrvr.org/track/cmf/
70 B
265 B
Image
General
Full URL
https://match.adsrvr.org/track/cmf/generic?ttd_pid=6j2k199&ttd_tpi=1&ttd_puid=853839932400296011&ttd_puid=bf5a31e4-f8cc-4396-8c5c-9988e5f8bd06
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
15.197.193.217 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
a12b7a488abeaa9e4.awsglobalaccelerator.com
Software
/
Resource Hash
8d70b3e6badb6973663b398d297bb32eaedd08826a1af98d0a1cfce5324ffce0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 21 Sep 2022 21:18:56 GMT
cache-control
private,no-cache, must-revalidate
x-aspnet-version
4.0.30319
content-type
image/gif
content-length
70
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
nextroll-32x32.png
s.adroll.com/i/favicon/
2 KB
2 KB
Image
General
Full URL
https://s.adroll.com/i/favicon/nextroll-32x32.png
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:225e:9e00:6:9280:1080:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
bcaf0e3f087296133e0a996ee3d289a8d1a690147c93e0ab62019b505e6f9355

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

X-Amz-Version-Id
eTpwxbAIDHDUN.4tfrROIgU_pzKN9Xh0
Via
1.1 70d755f7200c02162c7545e4ce74649a.cloudfront.net (CloudFront)
Etag
"403a0a7dcf2d617e7ea852bfb9d11945"
Age
70553
X-Amz-Server-Side-Encryption
AES256
X-Cache
Hit from cloudfront
Connection
keep-alive
Vary
Accept-Encoding
Content-Length
1615
Last-Modified
Mon, 28 Jun 2021 18:19:21 GMT
Server
AmazonS3
Date
Wed, 21 Sep 2022 01:44:14 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
image/png
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
false
X-Amz-Cf-Pop
FRA60-P4
Accept-Ranges
bytes
Access-Control-Allow-Headers
*
X-Amz-Cf-Id
bCv9Sn-04FZC5zhpESI2DOeLPhRS4x6zr3lKNtRtf6IbSVZLsMje3A==
/
vtrk.doubleverify.com/
0
186 B
Ping
General
Full URL
https://vtrk.doubleverify.com/?v=1&t=event&ec=page&cd105=%40dvpub%2Fsignals-pagetag%400.0.2&cid=a7863245-dc61-466d-ad77-b81b779621cd&z=853965109706&ctx=20083417&cd160=89d0662e-cc5c-4b07-b6f2-fc8930245dc6&cd161=https%3A%2F%2Fwww.cancernetwork.com%2Fview%2Fneoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer&ea=load-signals&cd191=74e5d6120de80200&cd180=network&cm180=216&cm181=0&cm182=0&cm183=136&cm184=77&cm185=1&cm186=223&cm170=1&cd187=ids%20iqc%2Fhc&cm187=23&cd171=84192003%2C84191001%2C84081001%2C84082011&cd188=bsc%20iqc%2Fhc&cm188=10&cd189=vlp%20kv&cm189=26&cm190=18&cd190=rauth%20kv&cm191=26&cd175=%7B%22d0397491-5eee-4371-9e9d-8d9806707358%22%3A%7B%22VLP%22%3A%228%22%7D%2C%224dcf114c-7e3c-4b98-bd7e-105f43fdfb86%22%3A%7B%22VLP%22%3A%229%22%7D%2C%228cd31e18-0922-4c64-a24c-40dd5954d904%22%3A%7B%22VLP%22%3A%229%22%7D%2C%2213f0d18a-a02c-407d-8437-459930cc1e6e%22%3A%7B%22VLP%22%3A%220%22%7D%2C%2297b9ab6d-fb27-4d0c-910c-fa1c3b0db4f6%22%3A%7B%22VLP%22%3A%229%22%7D%2C%2291ea63e3-388a-491a-8446-7061720be220%22%3A%7B%22VLP%22%3A%229%22%7D%7D&cm192=0&cmp=DV464021
Requested by
Host: pub.doubleverify.com
URL: https://pub.doubleverify.com/signals/pub.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.213.31.46 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-213-31-46.eu-west-1.compute.amazonaws.com
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.cancernetwork.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36

Response headers

access-control-allow-origin
https://www.cancernetwork.com
date
Wed, 21 Sep 2022 21:18:56 GMT
cache-control
no-cache
access-control-allow-credentials
true
server
nginx
vary
Origin
access-control-allow-methods
GET, POST, OPTIONS
vitals
vitals.vercel-insights.com/v1/
2 B
133 B
Ping
General
Full URL
https://vitals.vercel-insights.com/v1/vitals
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/_next/static/chunks/main-199da08254673e78.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.220.167.71 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-220-167-71.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
565339bc4d33d72817b583024112eb7f5cdf3e5eef0252d6ec1b9c9a94e12bb3

Request headers

Referer
https://www.cancernetwork.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

date
Wed, 21 Sep 2022 21:18:56 GMT
x-ratelimit-reset
58
x-ratelimit-limit
1000
content-length
2
x-ratelimit-remaining
999
content-type
text/plain; charset=utf-8
vitals
vitals.vercel-insights.com/v1/
2 B
134 B
Ping
General
Full URL
https://vitals.vercel-insights.com/v1/vitals
Requested by
Host: www.cancernetwork.com
URL: https://www.cancernetwork.com/_next/static/chunks/main-199da08254673e78.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.220.167.71 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-220-167-71.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
565339bc4d33d72817b583024112eb7f5cdf3e5eef0252d6ec1b9c9a94e12bb3

Request headers

Referer
https://www.cancernetwork.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

date
Wed, 21 Sep 2022 21:18:56 GMT
x-ratelimit-reset
51
x-ratelimit-limit
1000
content-length
2
x-ratelimit-remaining
999
content-type
text/plain; charset=utf-8
/
www.facebook.com/tr/ Frame 7CC2
0
18 B
Document
General
Full URL
https://www.facebook.com/tr/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Content-Type
application/x-www-form-urlencoded
Origin
https://www.cancernetwork.com
Referer
https://www.cancernetwork.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/105.0.5195.125 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

access-control-allow-credentials
true
access-control-allow-origin
https://www.cancernetwork.com
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length
0
content-type
text/plain
cross-origin-resource-policy
cross-origin
date
Wed, 21 Sep 2022 21:18:56 GMT
priority
u=0
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
s7.addthis.com
URL
https://s7.addthis.com/static/sh.f48a1a04fe8dbf021b4cda1d.html
Domain
region1.analytics.google.com
URL
https://region1.analytics.google.com/g/collect?v=2&tid=G-RYRWC30G4W&gtm=2oe9j0&_p=1545303638&cid=679651309.1663795133&ul=en-us&sr=1600x1200&_z=ccd.v9B&sid=1663795133&sct=1&seg=0&dl=https%3A%2F%2Fins1.caboodleai.net%2Fen%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin&dt=INS%20-%20Neoadjuvant%20Pegylated%20Lipsomal%20Doxorubicin%2FCyclophosphamide%20Plus%20Trastuzumab%2FPertuzumab%20Yields%20Promising%20Efficacy%20in%20HER2%2B%20Breast%20Cancer&_s=2
Domain
region1.google-analytics.com
URL
https://region1.google-analytics.com/g/collect?v=2&tid=G-1J5889RZEV&gtm=2oe9j0&_p=1545303638&cid=679651309.1663795133&ul=en-us&sr=1600x1200&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&_z=ccd.v9B&sid=1663795133&sct=1&seg=0&dl=https%3A%2F%2Fins1.caboodleai.net%2Fen%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin&dt=INS%20-%20Neoadjuvant%20Pegylated%20Lipsomal%20Doxorubicin%2FCyclophosphamide%20Plus%20Trastuzumab%2FPertuzumab%20Yields%20Promising%20Efficacy%20in%20HER2%2B%20Breast%20Cancer&_s=2
Domain
m.addthis.com
URL
https://m.addthis.com/live/red_lojson/100eng.json?sh=0&ph=1200&ivh=1200&dt=1198&pdt=1146&ict=&pct=0&perf=widget%7C1146%7C435%2Clojson%7C1733%7C180%2Csh%7C1736%7C24&rndr=render_toolbox%7C1833&cmenu=null&ppd=0&ppl=0&fbe=&xmv=0&xms=0&xmlc=0&jsfw=angular%2Cjquery%2Clodash%2Cclassie%2Cgoogleanalytics&jsfwv=angular-1.5.0%2Cjquery-1.11.2%2Clodash-4.17.4%2Cclassie-unk%2Cgoogleanalytics-analytics.js&al=men&scr=0&scv=0&apiu=1&ba=3&sid=632b7fbdbbf615c9&rev=v8.28.8-wp&pub=ra-5f4f5c0b0070a69b&dp=ins1.caboodleai.net&fp=en%2Farticle%2F165823%2Fneoadjuvant-pegylated-lipsomal-doxorubicin&pfm=0&icns=

Verdicts & Comments Add Verdict or Comment

194 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| onbeforeinput object| oncontextlost object| oncontextrestored function| structuredClone object| launchQueue object| onbeforematch function| getScreenDetails function| queryLocalFonts object| navigation undefined| __CSP_NONCE object| litHtmlVersions function| _0x2f23 function| _0x53f5 function| lassoImpID object| dataLayer object| PQ object| analytics string| LassoImpressionID function| Krux object| google_tag_manager function| hj object| _hjSettings function| fbq function| _fbq string| adroll_adv_id string| adroll_pix_id string| adroll_version boolean| __adroll_loaded object| adroll object| webpackChunk_N_E object| webpackChunk_segment_analytics_next string| analyticsWriteKey object| __SEGMENT_INSPECTOR__ object| AnalyticsNext object| regeneratorRuntime object| next object| __NEXT_DATA__ function| __SSG_MANIFEST_CB object| __NEXT_P object| _N_E object| core object| global object| System function| asap function| Observable function| setImmediate function| clearImmediate boolean| _babelPolyfill function| _ object| DIGIOH_API object| DIGIOH_VARS object| DIGIOH_CUSTOM_JS_GLOBAL object| DIGIOH_CUSTOM_JS_SUPER object| DIGIOH_CUSTOM_JS string| DIGIOH_VENDOR_GUID string| DIGIOH_VENDOR_SHORT_ID string| DIGIOH_KEEN_WRITE_KEY string| DIGIOH_CDN_DOMAIN string| DIGIOH_CLIENT_IP string| DIGIOH_CACHE_VERSION string| DIGIOH_STORAGE_TYPE string| DIGIOH_EMBED_TYPE object| DIGIOH_LIGHTBOX_CONDITIONS object| DIGIOH_LIGHTBOX_RULESETS object| DIGIOH_LIGHTBOX_EFFECTS object| DIGIOH_LIGHTBOX_NAMES object| DIGIOH_LIGHTBOX_IDS object| DIGIOH_VARIATION_TO_BOX_MAP object| DIGIOH_PIXEL_THRESHOLDS object| DIGIOH_PUBLISHED_VARIATIONS_ARR object| DIGIOH_DATA_STORAGE_TYPE_BY_BOX_OBJ object| DIGIOH_PRIMARY_VARIATIONS_ARR object| DIGIOH_EFFECTS_IMAGE_CACHE_ARR object| DIGIOH_SETTINGS_IMAGE_CACHE_ARR object| DIGIOH_LIGHTBOX_MASTER_RULES object| DIGIOH_LIGHTBOX_TEASER_PRELOAD_ARR object| DIGIOH_LIGHTBOX_TEASER_FOLLOW_ME_ARR object| DIGIOH_LIGHTBOX_INLINE_ALWAYS_ARR object| DIGIOH_LIGHTBOX_INLINE_CONDITIONS_ARR object| DIGIOH_LIGHTBOX_INLINE_DEPENDENT_ARR object| DIGIOH_LIGHTBOX_PRELOAD_ARR object| DIGIOH_LIGHTBOX_MOBILE_DEVICE_ARR object| DIGIOH_LIGHTBOX_DESKTOP_DEVICE_ARR object| DIGIOH_LIGHTBOX_UNCATEGORIZED_DEVICE_ARR object| DIGIOH_DYNAMIC_BOXES object| DIGIOH_SPLIT_TESTS_ARR boolean| DIGIOH_USE_BUGSNAG boolean| DIGIOH_USE_CONSOLE boolean| DIGIOH_USE_RESPONSIVE boolean| DIGIOH_USE_REAL_TIME_SUBMISSIONS boolean| DIGIOH_USE_HTTPS_ONLY boolean| DIGIOH_IS_QA boolean| DIGIOH_IS_PREVIEW boolean| DIGIOH_IS_DEV boolean| DIGIOH_KEEN_PV string| DIGIOH_BLIP_LZ object| COUPON_GROUP_POPULATE_OBJ number| ClientJsDomMaxWaitSeconds object| CDP_VARS boolean| USE_LZ object| ACCOUNT_METADATA object| DIGIOH_WIN_PARENT object| DIGIOH_DOC_PARENT object| DIGIOH_WIN_CHILD object| DIGIOH_LIGHTBOX_ANALYTICS object| DIGIOH_BUGSNAG object| LZString function| JQUERY_DIGIOH boolean| hasRunJquerySelectorGenerator object| JquerySelectorGeneratorPrevBorder string| JquerySelectorGeneratorPrevPath function| runJquerySelectorGenerator object| DIGIOH_STORAGE object| DIGIOH_LOCAL_STORAGE object| DIGIOH_CROSS_DOMAIN object| DIGIOH_COOKIE object| DIGIOH_IS_ANALYTICS_IDENTIFY_DONE object| DeviceAtlas function| DIGIOH_ANALYTICS object| CJSAPPS_ARR object| CJSAPPS_PARENT function| Keen undefined| $ undefined| jQuery object| LIGHTBOX_API boolean| SENT_LIGHTBOX_PV undefined| jQuery171043735176183430857_1663795135688 function| saveAs string| GoogleAnalyticsObject function| ga boolean| GA_INITIALIZED object| googletag object| __BUILD_MANIFEST object| __SSG_MANIFEST object| __MIDDLEWARE_MANIFEST object| hjSiteSettings function| hjBootstrap object| hjBootstrapCalled object| hjLazyModules object| google_js_reporting_queue number| google_srt object| google_logging_queue number| tmod object| google_ad_modifications object| ggeac object| google_persistent_state_async boolean| google_measure_js_timing object| google_tag_data object| google_reactive_ads_global_state object| adsbygoogle boolean| _gfp_a_ object| google_sa_queue function| google_process_slots function| google_spfd number| google_unique_id object| google_sv_map number| google_rum_task_id_counter boolean| dv-data-transparency-tag-active function| dv-data-transparency-top-level-monitoring function| __adroll__ string| adroll_sid object| __adroll function| __cmp function| __tcfapi boolean| adroll_sendrolling_cross_device object| adroll_form_fields function| adroll_tpc_callback string| google_user_agent_client_hint object| gaplugins object| gaGlobal object| gaData object| ube object| __adroll_consent_data object| adroll_exp_list function| google_sa_impl object| googleToken object| googleIMState string| hh24 string| hh24et object| __adroll_consent boolean| __adroll_consent_is_gdpr string| __adroll_consent_user_country string| __adroll_consent_adv_country string| lassoMeasurementDivName object| lassoMeasurement object| $jscomp string| BANNER_VERSION string| TCF_VERSION string| IABWRITE_NO_COOKIE object| __adroll_consent_banner object| __adroll_consent_prev_lastchild

42 Cookies

Domain/Path Name / Value
www.cancernetwork.com/view Name: prevSlugs
Value: %22neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer%22
www.cancernetwork.com/view Name: localHistory
Value: %5B%22%2Fview%2Fneoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer%22%5D
ins1.caboodleai.net/ Name: language
Value: en
ins1.caboodleai.net/ Name: anonymousId
Value: 38622e25-c93d-47ce-9690-5a860c75cf25
ins1.caboodleai.net/ Name: ASP.NET_SessionId
Value: 3j4jnvbakql5hhbcyxtk1d1z
ins1.caboodleai.net/ Name: IndustryTrackerMainCookie
Value: {"IsInternalUser":false,"UserDisplayNameCookie":"","IsAdmin":false,"IsAuthenticated":false,"IsTrackerUser":false,"IsCompanyUser":false,"IsSubscriber":false,"IsNotAdminBackofficeUser":false,"ConfirmSubscription":false,"UserId":null,"SubscriberId":null,"AnonymousId":"38622e25-c93d-47ce-9690-5a860c75cf25","IsOrginizerAdmin":false}
ins1.caboodleai.net/ Name: isAdBlockerEnabled
Value: true
ins1.caboodleai.net/ Name: cookieSiteNameId
Value: ins1
ins1.caboodleai.net/ Name: __RequestVerificationToken
Value: NDeDeiitRK4-NYAgtXlH9O1JSeLaEtXkAj9Dooz_QBT9_Pku0FvSTbrRWxCbOrfQZ5YaVhDOhyibh1RzLbxk51MADIY1
.caboodleai.net/ Name: _gid
Value: GA1.2.1595459267.1663795133
.caboodleai.net/ Name: _gat
Value: 1
.caboodleai.net/ Name: _gat_groupTracker
Value: 1
.caboodleai.net/ Name: _gcl_au
Value: 1.1.1970089788.1663795133
.caboodleai.net/ Name: _gat_UA-168107088-1
Value: 1
ins1.caboodleai.net/ Name: __atuvc
Value: 1%7C38
ins1.caboodleai.net/ Name: __atuvs
Value: 632b7fbd50c46c55000
.caboodleai.net/ Name: _ga
Value: GA1.1.679651309.1663795133
.addthis.com/ Name: uvc
Value: 1%7C38
.addthis.com/ Name: loc
Value: MDAwMDBFVURFQlkyMjk1MTkwMjAwNTAwMDBDSA==
.linkedin.com/ Name: UserMatchHistory
Value: AQLN76E8C34TJgAAAYNh6vwA609RQbcKxfbkpcZTelAFv2Lt4lYmDAGNoff-737QnvNq6JcIB9xSGg
.linkedin.com/ Name: AnalyticsSyncHistory
Value: AQKGrSBMaLz2YwAAAYNh6vwAnuklHzbqG6BLaRaCmYZGwZSpw_pHzy06O9UCJYjrIID2KUXeuZI8wkZIIYLxIQ
.ads.linkedin.com/ Name: lang
Value: v=2&lang=en-us
.linkedin.com/ Name: bcookie
Value: "v=2&1ea65a74-14c2-45a3-8cf2-ee5d0e547fdd"
.linkedin.com/ Name: lidc
Value: "b=TGST06:s=T:r=T:a=T:p=T:g=2513:u=1:x=1:i=1663795133:t=1663881533:v=2:sig=AQEoxbq3r7o-5xJBn3HPboVAbo4nEAIJ"
.linkedin.com/ Name: lang
Value: v=2&lang=de-de
.www.linkedin.com/ Name: bscookie
Value: "v=1&20220921211853816b03e1-d1fd-48ac-861f-b91d45381578AQEKGCnM7mcrn0MQvsia2VacIdOO4xAH"
.linkedin.com/ Name: li_gc
Value: MTswOzE2NjM3OTUxMzM7MjswMjGgTotSTmWYBWZD5TZCTRkIl1pCmNCVY2W0VjsCcLL7sw==
.caboodleai.net/ Name: _ga_RYRWC30G4W
Value: GS1.1.1663795133.1.0.1663795135.58.0.0
.caboodleai.net/ Name: _ga_1J5889RZEV
Value: GS1.1.1663795133.1.0.1663795135.0.0.0
.cancernetwork.com/ Name: _ga
Value: GA1.2.330794310.1663795136
.cancernetwork.com/ Name: _gid
Value: GA1.2.1255294185.1663795136
.cancernetwork.com/ Name: _gat_ga_id_1
Value: 1
.cancernetwork.com/ Name: _gat_ga_id_2
Value: 1
.cancernetwork.com/ Name: _fbp
Value: fb.1.1663795136077.1667531310
.cancernetwork.com/ Name: ajs_anonymous_id
Value: 388c31ed-0451-49d2-aef7-6f021accabd1
.facebook.com/ Name: fr
Value: 0FeWlkfh6WjdkOTSU..BjK3_A...1.0.BjK3_A.
.adnxs.com/ Name: uuid2
Value: 853839932400296011
.cancernetwork.com/ Name: _hjSessionUser_2139334
Value: eyJpZCI6ImQyYTE3MWQ0LTNlMWUtNTVhYS1iOGRjLTkyN2Q1MmYzZWFiMCIsImNyZWF0ZWQiOjE2NjM3OTUxMzYwNDMsImV4aXN0aW5nIjpmYWxzZX0=
.cancernetwork.com/ Name: _hjFirstSeen
Value: 1
www.cancernetwork.com/ Name: _hjIncludedInSessionSample
Value: 0
.cancernetwork.com/ Name: _hjSession_2139334
Value: eyJpZCI6IjQ4YjdjZTgwLTRkYWQtNGUwNy1iOWM2LTZjOTFlZGM0YzNlMCIsImNyZWF0ZWQiOjE2NjM3OTUxMzYxNzIsImluU2FtcGxlIjpmYWxzZX0=
.cancernetwork.com/ Name: _hjAbsoluteSessionInProgress
Value: 0

1 Console Messages

Source Level URL
Text
security error URL: https://www.cancernetwork.com/view/neoadjuvant-pegylated-lipsomal-doxorubicin-cyclophosphamide-plus-trastuzumab-pertuzumab-yields-promising-efficacy-in-her2-breast-cancer
Message:
Refused to execute script from 'https://match.adsrvr.org/track/cmf/generic?ttd_pid=v0gsn3b&ttd_tpi=1&ttd_puid=582&ttd_puid=null&ttd_puid=853839932400296011&ttd_puid=&ttd_puid=ec6fd4e3-ce97-4f29-b582-67026bc49faf' because its MIME type ('image/gif') is not executable.

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

a5122525b8ca47d59e1e515e20e1c65a.js.ubembed.com
api.segment.io
assets.ubembed.com
cdn.sanity.io
cdn.segment.com
cmp.osano.com
connect.facebook.net
d.adroll.com
fonts.googleapis.com
fonts.gstatic.com
googleads.g.doubleclick.net
ins1.caboodleai.net
lightboxapi.azurewebsites.net
m.addthis.com
match.adsrvr.org
maxcdn.bootstrapcdn.com
mjh-web.s3.amazonaws.com
pagead2.googlesyndication.com
pub.doubleverify.com
px.ads.linkedin.com
px4.ads.linkedin.com
region1.analytics.google.com
region1.google-analytics.com
res.lassomarketing.io
s.adroll.com
s7.addthis.com
script.hotjar.com
secure.adnxs.com
securepubads.g.doubleclick.net
snap.licdn.com
static.hotjar.com
stats.g.doubleclick.net
trc.lhmos.com
u27622772.ct.sendgrid.net
v1.addthisedge.com
vars.hotjar.com
vitals.vercel-insights.com
vtrk.doubleverify.com
www.cancernetwork.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.lightboxcdn.com
www.linkedin.com
z.moatads.com
m.addthis.com
region1.analytics.google.com
region1.google-analytics.com
s7.addthis.com
104.75.88.126
108.138.17.27
13.107.42.14
15.197.193.217
151.101.129.131
167.89.115.121
18.66.115.169
18.66.147.113
18.66.97.37
185.89.210.141
20.40.202.0
2001:4860:4802:32::36
2001:4860:4802:34::36
23.35.237.151
23.36.162.19
2600:9000:223c:f200:3:b7e:8940:93a1
2600:9000:225e:9e00:6:9280:1080:93a1
2606:4700::6810:50a5
2606:4700::6812:a6e0
2606:4700::6812:bcf
2620:1ec:21::14
2a00:1450:4001:809::2003
2a00:1450:4001:80b::2002
2a00:1450:4001:80f::200e
2a00:1450:4001:812::200a
2a00:1450:4001:827::2002
2a00:1450:4001:829::2004
2a00:1450:4001:82f::2003
2a00:1450:4001:830::2002
2a00:1450:4001:831::2008
2a00:1450:400c:c08::9a
2a02:26f0:11a::6867:4868
2a03:2880:f01c:8012:face:b00c:0:3
2a03:2880:f11c:8183:face:b00c:0:25de
34.102.246.198
35.190.70.79
35.244.182.184
52.213.31.46
52.216.80.240
52.222.236.122
52.25.176.52
54.220.167.71
63.33.188.239
76.76.21.123
01cd865d937d42f4dc43c8a56ca98e550fde1ab58c1ab3af42f382c15b7c5c21
0537b568ba2b8f91354e1e39dbd2b1c41ef72fdcff56d12405f9c34f0b1d6161
06223f06cd0ba37084e1fd7cea7b987771b95e4b45733b400e7f9aede5189076
08ce75934a60623ed7afce900c892ff09712c8bab5d7ef6c48830748b61bd90c
0b9028c7ecccf4f31fafcfca176cd6ed38197d7b3d6ea4c107b98af8eecc525b
0cb973a20baeddd8a31369c9e5e38d06a90e76e1fe891ba003680ab99f160059
0fb1bbca73646e8e2b93c82e8d8b219647b13d4b440c48e338290b9a685b8de1
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
12f71cb993958eefc4bdb41d7dbbda490779a9c7aba448f7be52bb63912e0254
1338e5f665c71991f20670be7ff77fdfe17c6f376391023f2803a7ba7284d373
202d798492f754ba5c144a165aa9600d24bf5df0043fa006330f27d51f982097
244de2849ff5effe874d220c6920b3ac2d5d8019f521037a37525c563b32e8c6
269aedd08bf7bb55f54bc040553bb7a8fa82d4bf511f6f9905122c965dda8115
2838ada1a2e98ea67fbff5622ae6dbc293c5cae3f50be29febaa03b9a4bd8627
34af564a0d4ef2671f1164feb469b6c201e249cb0f78e22ab5804fd8f32ce1d3
37bea528a2323f0df68b7ac367c4d42f64ea46c73e9bbf05a3632cd8f4c94052
38748c405369b6286c3e5385c5f95ee20704f398ef1afe7cbe7c28de7fbec30d
3a023012719781cbb475aa6cd0c777a9d8112b330157a49b1068ff8b8b7e0297
3be252a3c458dba4d7d04e3d6dafa8ce034f2d7318b6f9eb3557074d46579e80
3f426106a46b512bbc0f3acde5fe83bd20296b70727d160c5773a1bc8b77b7e0
3f9e0fa424ecf2bdb9c3bca8fa668a3ce13d4124b2ba5878bfe5307c6d415e15
41c92be57defe929019543beed19864e338c49494c5926c14a094021026744c1
42713036ca5c6ef66f3d205b827dfa1ed884bd0f4c0b1d5fa52c259b8957ab54
45169abf0c7bb67cf7708983ec00a7c62c8beddb556112ec1ae79de86c8c9681
498dc2c813769b287a426368520eedb183e368fd6cb852f45ea24968a1f773b5
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
4cd895241257c20165b479591104acd17956489c2d7de88fb72746de411434b0
54502058e97eaac693950652b3243bf71346305b1b3c5a2fa479c27dd8d5a73f
55de8fe308830545a7ea4f837f6b9f0b3d6e5afbf9fe351f316484c715176141
565339bc4d33d72817b583024112eb7f5cdf3e5eef0252d6ec1b9c9a94e12bb3
5b31d7b87e269f44bc9c6e66dd1d6bf2f40f2b91a1314cbe21bb84a36d0f1b68
5d39c4065e4526981e9e4ac4a21a840e10d57d2d336abc5d6b3976a983165e1e
5fb2cd600b2b3a2c564c5c9ab1a78b92d0cfa8657f77e1d88159ac3ea575f749
64a6c1c3db90c284d35d86f4c382245a3abcb294563e5968be37a03751794106
664c76e65bd287c6c8ed18189bd288e672703482528352b995fa398b9b001a06
6f5b4aa00d2f8d6aed9935b471806bf7acef464d0c1d390260e5fe27f800c67e
7e77bb2a841fa5913398a32de629621b5c9c1b9674d6f9622e4b2002761333a8
7f4d6285789a95df776bb0a1fc1201107b75dbe78cbaeb404f5b5d340fcefc09
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
8391b947d3af4fbebaed9ed32ec99db7f43b7a8336fde277eaa2ae1629c797eb
844bfb2ff3311ad9b5611b51d8c72e0c483a8ceafe7c625a5c321637f9277399
84e01419bd81f32ac6df0f75f49c604fda9172000a3ae432b3c47b2a6a712d80
85fa85cbca5efaa81351f2e9b1e8e53916644bff91da6ffc762a151247501ebc
867b23a408fa99143955de5665345cda886857174c328d2828e5dcd33bd98cd1
8778e9af2422858d7052ff9a0f3c12c08ae976bdd6e0316db144cd5579cd97db
89ab81ca7e3e2d2e7e166ccbc0b3de59d32ea014d21e29376652096e2fc8f669
8d70b3e6badb6973663b398d297bb32eaedd08826a1af98d0a1cfce5324ffce0
8ff3bca5ba5be1071435d11107289b38b1129f5c6a4b62626cbc7981caa93c34
90a9ae3e06adde637f610ff1371192aeadae1d9051a092e93f324ab95778ea33
91144fbcc0e3f609b021e362ec29d2a9b58f15e840f229eb99ea2c04d927882b
98c8d155b2ee4c887bcdc446135d70a43fa31603f7eee3fb935c7233d8638470
9a422058735af0ef6190cb555b6117d889697ec56c776b795225de10139e12f9
9abdea148f6bb2fd5f4d3a947661b46f077584cfc3691deb29fa7cb25d2e00a6
9e25469f734732205f33dd80ff8ca12080406c18d2fa99a1f368103e51f7999f
9e83216908224ffbc39992a5e60f93ca21b8e2240ba28025ba679c4b70f7112d
9ff1a2c61f11af0dea73a96fe17c1710b263a1aa98ad545edf1fed8893f304a4
a048e640908046be06e00eab37742b5d5ff80964af58cfd22f7cb2de4dfe375f
a0e061fcb058418dd1f5e931707cd37aceeed877fcae25766c43426d36d6903d
a1f04990cdf9746528e6a613ae69fb5f3bc54c3677b6a3865af0c873d880b4fe
a675d717cc543f1736920ce540e27ef6aaabe6edf9353d1e49daed1d795f06ef
a9bac6d9739317499e2b097eb6a92140533aed862ca76e90e264a148a0aa5b51
acd2f7ad78edeebad4b6b0fdd17ff57d81c3726c60fd5435ee8c5a0115d29403
ad380a37653ca56006070f0279da2ef726318b5bf99f8069449d8edc0439166b
ae187a7bdae6e9f17b9ecc6fcd91a51e2e0c48d1776188064edfd119ac9d8177
ae4279f86fc1e616f6c238f6132acb6b5721fb3913d4b772da7434475606e590
ae549167ef2e43019e58d4e8c3f9874b9647abf0aa042c1062f39d36559fbb69
ae9cf477a2efc30bfbb6ecacefa952a7e97808d14bd41bed0d28834c660bba47
aec60bc104db041b1512185839f18f52986df7e569e5445f740dd60f763fbca8
b019538234514166ec7665359d097403358f8a4c991901983922fb4d56989f1e
b2f8f1ff372ffe802c4af0512bc6a6e7ecbd27548ac2d8ea7bb465f45b9c470b
b318b179b35ca92c87626801798f3bce3864172926ae10288f0460a53f30177c
b66e48a68d0828a03031d342f6ff41c9888bdca8bf594dc05b91e5d54d7259b6
b6ea52603aaaf6b4fa819f1ae9019bf500468131fa8f4e44305f9683309f9e84
b6eab2f0644e546b3e9172c755f42aca51e84425079096195ad0b8d35c7599fb
bcaf0e3f087296133e0a996ee3d289a8d1a690147c93e0ab62019b505e6f9355
c6881d5ada5d5d8707ea8687226606fffce4f632cbab34baf392f0cb73b5436b
d08edd63c00d47fd0777e717e1d4583d97c4a684245f87fd1e91bd7f1e0f428b
d5b6112d3ed969d3f4f3934a8bb08ef868f7b87b81cd0f21786250d37b84a67a
d75d72c8491fe13d0210b3f747f46ebb3bb248279e9f5ab2c40fdc7c120d6e94
d9e59641a8f690d854acb9ef992583e66381ce366a15c647043024a105852f96
da67d3a3dd7576d85d617f642cf8356992c5af5eb41cbbb7e049c121f534f9c2
dd897c508ba0c0d9af3a7c28d41a1c1d6f286a3a4935c6acaf49218cf8bb2b01
dda36ab0dda2b7ba616e824e0dd455eb222bf9fee24984c74e19df9fa962758e
de3246094525b21a870fc7d2a67490d0132535c6fa5993755c549f1a9d1bd8af
de5341313a4dc5d982ca50ae4a491e84bc5e80b0f439d87f05fc3973c1b7e59a
e184d6f703b75965543d91688c705698861b1376fa25f23a5cdbe7b8f66e63f3
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
e69b5114ae9adbf219fc9d8570c201f96b705916f9697f266ed98a751383ced9
e8771b238c60c36fc935fd2dad0aed6e70cea50a635ff4f89f394a968a258c42
ebb4310be8a1e03b277bc78005ff66c49ee546c62bb8d373b15f7f78ed3f4857
ef007a513c7d1c5019a27d62c5fa3413656a6414e51660422f27bf10b0cab84d
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
f59e5f34a941183aacaed25322ac0856628493c2cfd936ded3fddc0a49510e52
f5aebdfea35d1e7656ef4acc5db1f243209755ae3300943ef8fc6280f363c860
f6734f8177112c0839b961f96d813fcb189d81b60e96c33278c1983b6f419615
f6ea35e915c36564137473239a6de521526385c3096c2cfa3c9a3bfac343a1c1
f7408c25067cd0a9d9fe835cb4c05e394a50751d3fcde0c461db19a309abb02a
f896586d9d325e80cd7f39d8aa4b2fc5b9b4fabf1b337271920b400977784dff
f921ee583b32b0ffdbcf93a679f5983792f6c15af1fb9d756ec1047fac02ee04
fd3ca9b2d7793da992829ae484e4b1beb2c3cdf18dcaf7b53dac398f90782e2b
fdba01e144ba54810ca72aa9704485a14abcd89201985b561c49b1618ee4acad
fdf658733b627a9f4cd5ac14181b37f5dafbf0212402868602b80773ea8bba42